Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Previous issues

Page Path
HOME > Browse > Previous issues
18 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 35(5); October 2011
Prev issue Next issue
Reviews
Article image
2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea
Seung-Hyun Ko, Sung-Rea Kim, Dong-Joon Kim, Seung-Joon Oh, Hye-Jin Lee, Kang-Hee Shim, Mi-Hye Woo, Jun-Young Kim, Nan-Hee Kim, Jae-Taik Kim, Chong Hwa Kim, Hae Jin Kim, In-Kyung Jeong, Eun-Kyung Hong, Jae-Hyoung Cho, Ji-Oh Mok, Kun-Ho Yoon
Diabetes Metab J. 2011;35(5):431-436.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.431
  • 58,288 View
  • 51 Download
  • 99 Crossref
AbstractAbstract PDFPubReader   

As in other countries, type 2 diabetes is major health concern in Korea. A dramatic increase in the prevalence of type 2 diabetes and its chronic complications has led to an increase in health costs and economic burdens. Early detection of high risk individuals, hidden diabetic patients, and improvement in the quality of care for the disease are the first steps to mitigate the increase in prevalence. The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the '3rd Clinical Practice Guidelines' at the end of 2010. In the guidelines, the committee recommended active screening of high risk individuals for early detection and added the hemoglobin A1c level to the diagnostic criteria for type 2 diabetes based on clinical studies performed in Korea. Furthermore, the committee members emphasized that integrating patient education and self-management is an essential part of care. The drug treatment algorithm based on the degree of hyperglycemia and patient characteristics were also updated.

Citations

Citations to this article as recorded by  
  • Paradigm Shift in Management of Hyperglycemia in Patients with Type 2 Diabetes: Glucocentric versus Organ Protection
    Jong Chul Won
    The Journal of Korean Diabetes.2023; 24(2): 59.     CrossRef
  • Association of HbA1c with functional outcome by ischemic stroke subtypes and age
    Jihyun Jeong, Jae Kyung Park, Young Ho Koh, Jong-Moo Park, Hee-Joon Bae, Sang-Moon Yun
    Frontiers in Neurology.2023;[Epub]     CrossRef
  • Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines
    Soo Jin Yun, In-Kyung Jeong, Jin-Hye Cha, Juneyoung Lee, Ho Chan Cho, Sung Hee Choi, SungWan Chun, Hyun Jeong Jeon, Ho-Cheol Kang, Sang Soo Kim, Seung-Hyun Ko, Gwanpyo Koh, Su Kyoung Kwon, Jae Hyuk Lee, Min Kyong Moon, Junghyun Noh, Cheol-Young Park, Sung
    Diabetes & Metabolism Journal.2022; 46(3): 464.     CrossRef
  • Correlation between Serum Osmolarity and Creatinine in Health Check-Up Subjects (Examinees) with Diabetes
    Mi-Kyung Park, Geum-Seon Lee, Sun-Hee Kim, Mi-Eun Yun
    The Korean Journal of Community Living Science.2022; 33(2): 237.     CrossRef
  • Dietary antioxidant consumption and the risk of type 2 diabetes in South Korean adults: a prospective cohort study based on the Health Examinees study
    Li-Juan Tan, Su Bin Hwang, Shinyoung Jun, Hyojee Joung, Sangah Shin
    BMJ Open.2022; 12(7): e065073.     CrossRef
  • Investigating the Effectiveness of Very Low-Calorie Diets and Low-Fat Vegan Diets on Weight and Glycemic Markers in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Anjali Kashyap, Alexander Mackay, Ben Carter, Claire L. Fyfe, Alexandra M. Johnstone, Phyo K. Myint
    Nutrients.2022; 14(22): 4870.     CrossRef
  • Screening for Prediabetes and Diabetes in Korean Nonpregnant Adults: A Position Statement of the Korean Diabetes Association, 2022
    Kyung Ae Lee, Dae Jung Kim, Kyungdo Han, Suk Chon, Min Kyong Moon
    Diabetes & Metabolism Journal.2022; 46(6): 819.     CrossRef
  • Mobile Healthcare System Provided by Primary Care Physicians Improves Quality of Diabetes Care
    Tae Jung Oh, Jie-Eun Lee, Seok Kim, Sooyoung Yoo, Hak Chul Jang
    CardioMetabolic Syndrome Journal.2021; 1(1): 88.     CrossRef
  • Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000–2019
    Kyung Ae Lee, Heung Yong Jin, Yu Ji Kim, Yong-Jin Im, Eun-Young Kim, Tae Sun Park
    Journal of Korean Medical Science.2021;[Epub]     CrossRef
  • A Review on Metformin: Clinical Significance and Side Effects
    Mazumder Avijit, Singh Ashini
    Research Journal of Pharmacy and Technology.2021; : 6179.     CrossRef
  • Cardiovascular Disease among Patients with Diabetes: The Current Scenario in Saudi Arabia
    Asirvatham Alwin Robert, Mohamed Abdulaziz Al Dawish
    Current Diabetes Reviews.2021; 17(2): 180.     CrossRef
  • Association of Cardiometabolic Multimorbidity Pattern with Dietary Factors among Adults in South Korea
    Dawoon Jeong, Jieun Kim, Hansongyi Lee, Do-Yeon Kim, Hyunjung Lim
    Nutrients.2020; 12(9): 2730.     CrossRef
  • Comparison of effectiveness and drug cost between dipeptidyl peptidase‐4 inhibitor and biguanide as the first‐line anti‐hyperglycaemic medication among Japanese working generation with type 2 diabetes
    Noriko Ihana‐Sugiyama, Takehiro Sugiyama, Hirokazu Tanaka, Kohjiro Ueki, Yasuki Kobayashi, Mitsuru Ohsugi
    Journal of Evaluation in Clinical Practice.2020; 26(1): 299.     CrossRef
  • Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose
    Jie Huang, Wen‐yu Liu, Jing‐jing Yu, Jin‐bo Yang, Min Li, Chan Zou, Cheng‐xian Guo, Xiao‐yan Yang, Shuang Yang, Jin‐lian Xie, Zhi‐jun Huang, Hui Chen, Qi Pei, Guo‐ping Yang
    British Journal of Clinical Pharmacology.2020; 86(11): 2225.     CrossRef
  • Sex-, Age-, and Metabolic Disorder-Dependent Distributions of Selected Inflammatory Biomarkers among Community-Dwelling Adults
    So Mi Jemma Cho, Hokyou Lee, Jee-Seon Shim, Hyeon Chang Kim
    Diabetes & Metabolism Journal.2020; 44(5): 711.     CrossRef
  • Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin‐naïve people with type 2 diabetes: The EDITION AP randomized controlled trial
    Linong Ji, Eun Seok Kang, XiaoLin Dong, Ling Li, GuoYue Yuan, Shuhua Shang, Elisabeth Niemoeller
    Diabetes, Obesity and Metabolism.2020; 22(4): 612.     CrossRef
  • Effect of different dietary patterns on glycemic control in individuals with type 2 diabetes mellitus: A systematic review
    Gabrielli Barbosa de Carvalho, Natalia Lohayne Dias-Vasconcelos, Ramara Kadija Fonseca Santos, Paula Nascimento Brandão-Lima, Danielle Góes da Silva, Liliane Viana Pires
    Critical Reviews in Food Science and Nutrition.2020; 60(12): 1999.     CrossRef
  • Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
    Sang Ouk Chin, In Gyoon Ha, Sang Youl Rhee, Su Jin Jeong, Suk Chon, Sung Hoon Kim, Kyu Jeung Ahn, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Jeong Taek Woo
    International Journal of Endocrinology.2020; 2020: 1.     CrossRef
  • Chronic Hyperglycemia before Spinal Cord Injury Increases Inflammatory Reaction and Astrogliosis after Injury: Human and Rat Studies
    Ki-Su Park, Jin Bum Kim, Martin Keung, Ye Jin Seo, Sung Young Seo, Seul Ah Mun, Young-Seok Lee, Dae-Chul Cho, Jeong-Hyun Hwang, Inbo Han, Chi Heon Kim, Kyoung-Tae Kim
    Journal of Neurotrauma.2020; 37(9): 1165.     CrossRef
  • National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2 diabetes mellitus
    Jisu Kim, Susin Park, Hyunsoo Kim, Nam Kyung Je
    European Journal of Clinical Pharmacology.2019; 75(12): 1723.     CrossRef
  • Three-Dimensional Paper-Based Microfluidic Analytical Devices Integrated with a Plasma Separation Membrane for the Detection of Biomarkers in Whole Blood
    Chanyong Park, Hong-Rae Kim, Soo-Kyung Kim, In-Kyung Jeong, Jae-Chul Pyun, Sungsu Park
    ACS Applied Materials & Interfaces.2019; 11(40): 36428.     CrossRef
  • The Effect of Metformin on Prognosis in Patients With Locally Advanced Gastric Cancer Associated With Type 2 Diabetes Mellitus
    Ho Seok Seo, Yoon Ju Jung, Ji Hyun Kim, Han Hong Lee, Cho Hyun Park
    American Journal of Clinical Oncology.2019; 42(12): 909.     CrossRef
  • Discordance in prediction for prognosis of type 2 diabetes after metabolic surgery: comparison of the ABCD, DiaRem, and individualized metabolic surgery models
    Jane Ha, Yeongkeun Kwon, Nam Hoon Kim, Sungsoo Park, Emanuele Lo Menzo, Raul J. Rosenthal
    Annals of Surgical Treatment and Research.2019; 97(6): 309.     CrossRef
  • Discrepancies between Glycosylated Hemoglobin and Fasting Plasma Glucose for Diagnosing Impaired Fasting Glucose and Diabetes Mellitus in Korean Youth and Young Adults
    Jieun Lee, Young Ah Lee, Jae Hyun Kim, Seong Yong Lee, Choong Ho Shin, Sei Won Yang
    Diabetes & Metabolism Journal.2019; 43(2): 174.     CrossRef
  • 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
    Mee Kyoung Kim, Seung-Hyun Ko, Bo-Yeon Kim, Eun Seok Kang, Junghyun Noh, Soo-Kyung Kim, Seok-O Park, Kyu Yeon Hur, Suk Chon, Min Kyong Moon, Nan-Hee Kim, Sang Yong Kim, Sang Youl Rhee, Kang-Woo Lee, Jae Hyeon Kim, Eun-Jung Rhee, SungWan Chun, Sung Hoon Yu
    Diabetes & Metabolism Journal.2019; 43(4): 398.     CrossRef
  • Lack of Association between Past Helicobacter pylori Infection and Diabetes: A Two-Cohort Study
    Jeung Hui Pyo, Hyuk Lee, Sung Chul Choi, Soo Jin Cho, Yoon-Ho Choi, Yang Won Min, Byung-Hoon Min, Jun Haeng Lee, Heejin Yoo, Kyunga Kim, Jae J. Kim
    Nutrients.2019; 11(8): 1874.     CrossRef
  • Does Korean diet based on brown rice really have the effect on treating chronic diseases and on suspending drug use?
    Su Jin Jung, Baik Hwan Cho, Soo Wan Chae
    Journal of Ethnic Foods.2018;[Epub]     CrossRef
  • The effectiveness, reproducibility, and durability of tailored mobile coaching on diabetes management in policyholders: A randomized, controlled, open-label study
    Da Young Lee, Jeongwoon Park, Dooah Choi, Hong-Yup Ahn, Sung-Woo Park, Cheol-Young Park
    Scientific Reports.2018;[Epub]     CrossRef
  • Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index
    Kyoung Hwa Ha, Cheol Young Park, In Kyung Jeong, Hyun Jin Kim, Sang-Yong Kim, Won Jun Kim, Ji Sung Yoon, In Joo Kim, Dae Jung Kim, Sungrae Kim
    Diabetes & Metabolism Journal.2018; 42(2): 137.     CrossRef
  • Distribution of glycated haemoglobin and its determinants in Korean youth and young adults: a nationwide population-based study
    Ji-Young Seo, Seung-sik Hwang, Jae Hyun Kim, Young Ah Lee, Seong Yong Lee, Choong Ho Shin, Sei Won Yang
    Scientific Reports.2018;[Epub]     CrossRef
  • The relationship between age of onset and risk factors including family history and life style in Korean population with type 2 diabetes mellitus
    Jin-Won Noh, Jin Hee Jung, Jeong Eun Park, Jung Hwa Lee, Kang Hee Sim, Jumin Park, Min Hee Kim, Ki-Bong Yoo
    Journal of Physical Therapy Science.2018; 30(2): 201.     CrossRef
  • Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status
    Jong Chul Won, Jae Hyuk Lee, Jae Hyeon Kim, Eun Seok Kang, Kyu Chang Won, Dae Jung Kim, Moon-Kyu Lee
    Diabetes & Metabolism Journal.2018; 42(5): 415.     CrossRef
  • Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data
    Sejeong Park, Sang Youl Rhee, Su Jin Jeong, Kiyoung Kim, Suk Chon, Seung-Young Yu, Jeong-Taek Woo
    Diabetes & Metabolism Journal.2017; 41(5): 393.     CrossRef
  • Letter: Comparison of Age of Onset and Frequency of Diabetic Complications in the Very Elderly Patients with Type 2 Diabetes (Endocrinol Metab2016;31:416-23, Bong-Ki Lee et al.)
    Mee Kyoung Kim
    Endocrinology and Metabolism.2017; 32(1): 140.     CrossRef
  • The Cutoff Value of HbA1c in Predicting Diabetes and Impaired Fasting Glucose
    Seyoung Kwon, Youngak Na
    The Korean Journal of Clinical Laboratory Science.2017; 49(2): 114.     CrossRef
  • Changes in HbA 1c levels and body mass index after successful decompression surgery in patients with type 2 diabetes mellitus and lumbar spinal stenosis: results of a 2-year follow-up study
    Kyoung-Tae Kim, Dae-Chul Cho, Joo-Kyung Sung, Chi Heon Kim, Hyun Kang, Du Hwan Kim
    The Spine Journal.2017; 17(2): 203.     CrossRef
  • Validation of a Newly Developed Equation for Estimating Serum Apolipoprotein B: Associations with Cardiovascular Disease Surrogate Markers in Koreans
    Jong-Dai Kim, You-Cheol Hwang, Hong-Yup Ahn, Cheol-Young Park
    Yonsei Medical Journal.2017; 58(5): 975.     CrossRef
  • Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
    Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
    The Korean Journal of Internal Medicine.2017; 32(6): 947.     CrossRef
  • Diagnostic criteria for diabetes in China: are we pushing too much beyond evidence?
    X Ma, Y-L Zhang, Q Ji, Y Xing, H Pan, S Chen, J-L Tang, S Zhu
    European Journal of Clinical Nutrition.2017; 71(7): 812.     CrossRef
  • Patterns, control and complications of diabetes from a hospital based registry established in a low income country
    Jaweed Akhter, Asma Ahmed, Minaz Mawani, Laila Lakhani, Ayaz Kalsekar, Shehla Tabassum, Najmul Islam
    BMC Endocrine Disorders.2017;[Epub]     CrossRef
  • Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment
    Yanyun Gu, Xiaokai Wang, Junhua Li, Yifei Zhang, Huanzi Zhong, Ruixin Liu, Dongya Zhang, Qiang Feng, Xiaoyan Xie, Jie Hong, Huahui Ren, Wei Liu, Jing Ma, Qing Su, Hongmei Zhang, Jialin Yang, Xiaoling Wang, Xinjie Zhao, Weiqiong Gu, Yufang Bi, Yongde Peng,
    Nature Communications.2017;[Epub]     CrossRef
  • Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
    Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
    Diabetes & Metabolism Journal.2017; 41(5): 337.     CrossRef
  • Regional variations in frequency of glycosylated hemoglobin (HbA1c) monitoring in Korea: A multilevel analysis of nationwide data
    Kyoung-Hun Yoo, Dong-Wook Shin, Mi-Hee Cho, Sang-Hyuck Kim, Hyun-Jung Bahk, Shin-Hye Kim, Su-Min Jeong, Jae-Moon Yun, Jin-Ho Park, Heesun Kim, BeLong Cho
    Diabetes Research and Clinical Practice.2017; 131: 61.     CrossRef
  • Fasting plasma glucose concentrations for specified HbA1c goals in Korean populations: data from the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-2, 2011)
    Sangmo Hong, Jun Goo Kang, Chul Sik Kim, Seong Jin Lee, Chang Beom Lee, Sung-Hee Ihm
    Diabetology & Metabolic Syndrome.2016;[Epub]     CrossRef
  • Metabolic syndrome independently predicts future diabetes in women with a history of gestational diabetes mellitus
    Nam H. Cho, Chang Ho Ahn, Joon Ho Moon, Soo Heon Kwak, Sung Hee Choi, Soo Lim, Kyong Soo Park, Boyd E. Metzger, Hak C. Jang
    Medicine.2016; 95(35): e4582.     CrossRef
  • Feasibility of a Patient-Centered, Smartphone-Based, Diabetes Care System: A Pilot Study
    Eun Ky Kim, Soo Heon Kwak, Seungsu Baek, Seung Lyeol Lee, Hak Chul Jang, Kyong Soo Park, Young Min Cho
    Diabetes & Metabolism Journal.2016; 40(3): 192.     CrossRef
  • Effectiveness of Web-Based Interventions for Managing Diabetes in Korea
    Jee Young Joo
    CIN: Computers, Informatics, Nursing.2016; 34(12): 587.     CrossRef
  • Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
    Seon-Ah Cha, Jae-Seung Yun, Tae-Seok Lim, Seawon Hwang, Eun-Jung Yim, Ki-Ho Song, Ki-Dong Yoo, Yong-Moon Park, Yu-Bae Ahn, Seung-Hyun Ko
    Diabetes & Metabolism Journal.2016; 40(3): 202.     CrossRef
  • A Potential Issue with Screening Prediabetes or Diabetes Using Serum Glucose: A Delay in Diagnosis
    Jun Goo Kang, Cheol-Young Park, Sung-Hee Ihm, Sung Woo Park
    Diabetes & Metabolism Journal.2016; 40(5): 414.     CrossRef
  • Experiences of Diabetes Education among Educators of Diabetes : a content analysis approach
    Soo Jin Kang, Soo Jung Chang
    Journal of Korean Public Health Nursing.2016; 30(2): 221.     CrossRef
  • Efficient Strategy to Identify Gene-Gene Interactions and Its Application to Type 2 Diabetes
    Donghe Li, Sungho Won
    Genomics & Informatics.2016; 14(4): 160.     CrossRef
  • A patient-centric approach to optimise insulin therapy in Asia
    Su Yen Goh, Ernesto Ang, Shailendra Bajpai, Chaicharn Deerochanawong, Eun-Gyoung Hong, Zanariah Hussein, Shashank Joshi, Nor Azmi Kamaruddin, Sjoberg Kho, Alice Pik-Shan Kong, Chang Yu Pan, Riccardo Perfetti, Apichati Vichayanrat, Aleksandra Vlajnic, Juli
    Journal of Diabetes and its Complications.2016; 30(6): 973.     CrossRef
  • Glycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination Survey
    Sangmo Hong, Jun Goo Kang, Chul Sik Kim, Seong Jin Lee, Cheol-Young Park, Chang Beom Lee, Sung-Hee Ihm
    Diabetes & Metabolism Journal.2016; 40(2): 167.     CrossRef
  • Retrospective Observational Dose-Titration Study of Subjects with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on 15 mg of Pioglitazone
    So Young Ha, Hae Won Jung, Yong Jun Choi, Hyun Kyo Lee, Jong Wook Choi, Ji Hoon Choi, Jung Hyun Noh, Jae Won Hong, Dong-Jun Kim
    The Journal of Korean Diabetes.2016; 17(1): 51.     CrossRef
  • Upper-normal waist circumference is a risk marker for metabolic syndrome in normal-weight subjects
    R. Okada, Y. Yasuda, K. Tsushita, K. Wakai, N. Hamajima, S. Matsuo
    Nutrition, Metabolism and Cardiovascular Diseases.2016; 26(1): 67.     CrossRef
  • Optimal Glycemic and Hemoglobin A1c Thresholds for Diagnosing Diabetes Based on Prevalence of Retinopathy in an Iranian Population
    Naser Samadi Aidenloo, Alireza Mehdizadeh, Neda Valizadeh, Mohammad Abbaszadeh, Siavash Qarequran, Hamidreza Khalkhali
    Iranian Red Crescent Medical Journal.2016;[Epub]     CrossRef
  • Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002–2013
    Seung-Hyun Ko, Dae-Jung Kim, Jong-Heon Park, Cheol-Young Park, Chang Hee Jung, Hyuk-Sang Kwon, Joong-Yeol Park, Kee-Ho Song, Kyungdo Han, Ki-Up Lee, Kyung-Soo Ko
    Medicine.2016; 95(27): e4018.     CrossRef
  • Association between estimated blood glucose levels and glycated hemoglobin levels
    Seon-Ah Cha, Seung-Hyun Ko
    The Korean Journal of Internal Medicine.2016; 31(3): 457.     CrossRef
  • Uncontrolled diabetes mellitus: Prevalence and risk factors among people with type 2 diabetes mellitus in an Urban District of Karachi, Pakistan
    Fahad Javaid Siddiqui, Bilal Iqbal Avan, Sadia Mahmud, Debra J. Nanan, Abdul Jabbar, Pryseley Nkouibert Assam
    Diabetes Research and Clinical Practice.2015; 107(1): 148.     CrossRef
  • Assessment of glycemic control in patients with type 2 diabetes mellitus treated with metformin–sulfonylurea combination: Results of a multicenter, cross‐sectional, observational study in Korea
    Sin Gon Kim, Jong Ryeal Hahm, Duk Kyu Kim, Sung Rae Cho, Dong Seop Choi
    Journal of Diabetes Investigation.2015; 6(3): 317.     CrossRef
  • Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes
    Jae-Seung Yun, Seung-Hyun Ko
    The Korean Journal of Internal Medicine.2015; 30(1): 6.     CrossRef
  • The Correlation between Hemoglobin A1c and Common Carotid Artery Intima Medial Thickness of Both Genders with Less Than 6.5% HbA1c Based on Ultrasound Measurement
    Yeongju Ryu, Youngjin Park, Byeong Jin Ye
    Korean Journal of Health Promotion.2015; 15(2): 47.     CrossRef
  • Increased prevalence of albuminuria in individuals with higher range of impaired fasting glucose: the 2011 Korea National Health and Nutrition Examination Survey
    Jong Chul Won, Jae Won Hong, Jung Min Kim, Tae Nyun Kim, Jung Hyun Noh, Kyung Soo Ko, Byoung Doo Rhee, Dong-Jun Kim
    Journal of Diabetes and its Complications.2015; 29(1): 50.     CrossRef
  • The Association between Chronic Kidney Disease and Diabetic Retinopathy: The Korea National Health and Nutrition Examination Survey 2008-2010
    Young-Hoon Park, Jeong Ah Shin, Jae-Hyung Han, Yong-Moon Park, Hyeon Woo Yim, Harald Mischak
    PLOS ONE.2015; 10(4): e0125338.     CrossRef
  • Efficacy of a New Medical Information system, Ubiquitous Healthcare Service with Voice Inception Technique in Elderly Diabetic Patients
    Kyoung Min Kim, Kyeong Seon Park, Hyun Ju Lee, Yun Hee Lee, Ji Seon Bae, Young Joon Lee, Sung Hee Choi, Hak Chul Jang, Soo Lim
    Scientific Reports.2015;[Epub]     CrossRef
  • Intensive Individualized Reinforcement Education Is Important for the Prevention of Hypoglycemia in Patients with Type 2 Diabetes
    Yun-Mi Yong, Kyung-Mi Shin, Kang-Min Lee, Jae-Young Cho, Sun-Hye Ko, Min-Hyang Yoon, Tae-Won Kim, Jong-Hyun Jeong, Yong-Moon Park, Seung-Hyun Ko, Yu-Bae Ahn
    Diabetes & Metabolism Journal.2015; 39(2): 154.     CrossRef
  • The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea
    Seungjoon Oh, Suk Chon, Kyu Jeong Ahn, In-Kyung Jeong, Byung-Joon Kim, Jun Goo Kang
    Diabetes & Metabolism Journal.2015; 39(3): 177.     CrossRef
  • Clinical Characteristics of Subjects with Sulfonylurea-Dependent Type 2 Diabetes
    Se Hee Min, Soo Heon Kwak, Young Min Cho, Kyong Soo Park, Hye Seung Jung
    Endocrinology and Metabolism.2015; 30(4): 509.     CrossRef
  • Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes
    Jae-Seung Yun, Seung-Hyun Ko, Sun-Hye Ko, Ki-Ho Song, Ki-Dong Yoo, Kun-Ho Yoon, Yong-Moon Park, Yu-Bae Ahn
    Diabetes & Metabolism Journal.2015; 39(6): 498.     CrossRef
  • Association between flavonoid intake and diabetes risk among the Koreans
    Jee-Young Yeon, Yun Jung Bae, Eun-Young Kim, Eun-Ju Lee
    Clinica Chimica Acta.2015; 439: 225.     CrossRef
  • Association between Self-Reported Smoking and Hemoglobin A1c in a Korean Population without Diabetes: The 2011–2012 Korean National Health and Nutrition Examination Survey
    Jae Won Hong, Cheol Ryong Ku, Jung Hyun Noh, Kyung Soo Ko, Byoung Doo Rhee, Dong-Jun Kim, Barbara Fuhrman
    PLOS ONE.2015; 10(5): e0126746.     CrossRef
  • Relationship between metabolic syndrome and thyroid nodules in healthy Koreans
    Juyoung Shin, Min-Hee Kim, Kun-Ho Yoon, Moo-Il Kang, Bong-Yun Cha, Dong-Jun Lim
    The Korean Journal of Internal Medicine.2015; 31(1): 98.     CrossRef
  • Assessment of Cardiovascular Risk in Adults With Type 2 Diabetes and Metabolic Syndrome
    Chun-Ja Kim, Hee Sun Kang, Elizabeth A. Schlenk, Sun-Mi Chae
    The Diabetes Educator.2015; 41(2): 203.     CrossRef
  • Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea
    Jin-Hee Jung, Jung-Hwa Lee, Jin-Won Noh, Jeong-Eun Park, Hee-Sook Kim, Joo-Wha Yoo, Bok-Rye Song, Jeong-rim Lee, Myeong-Hee Hong, Hyang-Mi Jang, Young Na, Hyun-Joo Lee, Jeong-Mi Lee, Yang-Gyo Kang, Sun-Young Kim, Kang-Hee Sim
    Diabetes & Metabolism Journal.2015; 39(4): 307.     CrossRef
  • The number of metabolic syndrome components is a good risk indicator for both early- and late-stage kidney damage
    R. Okada, Y. Yasuda, K. Tsushita, K. Wakai, N. Hamajima, S. Matsuo
    Nutrition, Metabolism and Cardiovascular Diseases.2014; 24(3): 277.     CrossRef
  • Internet-Based Mentoring Program for Patients with Type 1 Diabetes
    Sun-Hye Ko, Seung-Hyun Ko
    Diabetes & Metabolism Journal.2014; 38(2): 107.     CrossRef
  • Association of Vitamin B12Deficiency and Metformin Use in Patients with Type 2 Diabetes
    Sun-Hye Ko, Sun-Hee Ko, Yu-Bae Ahn, Ki-Ho Song, Kyung-Do Han, Yong-Moon Park, Seung-Hyun Ko, Hye-Soo Kim
    Journal of Korean Medical Science.2014; 29(7): 965.     CrossRef
  • Plasma Glucose Regulation and Mortality in Korea: A Pooled Analysis of Three Community-Based Cohort Studies
    Nan Hee Kim, Dong-Jun Kim, Seok Won Park, Jee-Young Oh, Joong-Yeol Park, Chol Shin, Hong Kyu Lee, Yongsoo Park
    Diabetes & Metabolism Journal.2014; 38(1): 44.     CrossRef
  • The glycemic efficacies of insulin analogue regimens according to baseline glycemic status in Korean patients with type 2 diabetes: sub‐analysis from the A 1 chieve ® study
    Y.‐C. Hwang, J. G. Kang, K. J. Ahn, B. S. Cha, S.‐H. Ihm, S. Lee, M. Kim, B.‐W. Lee
    International Journal of Clinical Practice.2014; 68(11): 1338.     CrossRef
  • Higher Prevalence and Awareness, but Lower Control Rate of Hypertension in Patients with Diabetes than General Population: The Fifth Korean National Health and Nutrition Examination Survey in 2011
    Seung-Hyun Ko, Hyuk-Sang Kwon, Dae Jung Kim, Jae Hyeon Kim, Nan Hee Kim, Chul Sik Kim, Kee-Ho Song, Jong Chul Won, Soo Lim, Sung Hee Choi, Kyungdo Han, Yong-Moon Park, Bong-Yun Cha
    Diabetes & Metabolism Journal.2014; 38(1): 51.     CrossRef
  • Comparison between the Therapeutic Effect of Metformin, Glimepiride and Their Combination as an Add-On Treatment to Insulin Glargine in Uncontrolled Patients with Type 2 Diabetes
    Cheol-Young Park, Jun Goo Kang, Suk Chon, Junghyun Noh, Seung Joon Oh, Chang Beom Lee, Sung Woo Park, T. Mark Doherty
    PLoS ONE.2014; 9(3): e87799.     CrossRef
  • Glycaemic and haemoglobin A1c thresholds for detecting diabetic retinopathy: The fifth Korea National Health and Nutrition Examination Survey (2011)
    Yong-Moon Park, Seung-Hyun Ko, Jung-Min Lee, Dae-Jung Kim, Dong-Joon Kim, Kyungdo Han, Julie K. Bower, Yu-Bae Ahn
    Diabetes Research and Clinical Practice.2014; 104(3): 435.     CrossRef
  • Development of an HbA1c-Based Conversion Equation for Estimating Glycated Albumin in a Korean Population with a Wide Range of Glucose Intolerance
    Chang Hee Jung, You-Cheol Hwang, Kwang Joon Kim, Bong Soo Cha, Cheol-Young Park, Won Seon Jeon, Jae Hyeon Kim, Sang-Man Jin, Sang Youl Rhee, Jeong-taek Woo, Byung-Wan Lee, Sompop Bencharit
    PLoS ONE.2014; 9(4): e95729.     CrossRef
  • Risk of suicidal ideation in diabetes varies by diabetes regimen, diabetes duration, and HbA1c level
    Hoo-Yeon Lee, Myung-Il Hahm, Sang Gyu Lee
    Journal of Psychosomatic Research.2014; 76(4): 275.     CrossRef
  • Non-HDL cholesterol is an independent risk factor for aspirin resistance in obese patients with type 2 diabetes
    Jong Dai Kim, Cheol-Young Park, Kue Jeong Ahn, Jae Hyoung Cho, Kyung Mook Choi, Jun Goo Kang, Jae Hyeon Kim, Ki Young Lee, Byung Wan Lee, Ji Oh Mok, Min Kyong Moon, Joong Yeol Park, Sung Woo Park
    Atherosclerosis.2014; 234(1): 146.     CrossRef
  • Optimal glycated albumin cutoff value to diagnose diabetes in Korean adults: A retrospective study based on the oral glucose tolerance test
    You-Cheol Hwang, Chang Hee Jung, Hong-Yup Ahn, Won Seon Jeon, Sang-Man Jin, Jeong-taek Woo, Bong Soo Cha, Jae Hyeon Kim, Cheol-Young Park, Byung-Wan Lee
    Clinica Chimica Acta.2014; 437: 1.     CrossRef
  • Higher Prevalence of Metformin-Induced Vitamin B12 Deficiency in Sulfonylurea Combination Compared with Insulin Combination in Patients with Type 2 Diabetes: A Cross-Sectional Study
    Donghoon Kang, Jae-Seung Yun, Sun-Hye Ko, Tae-Seok Lim, Yu-Bae Ahn, Yong-Moon Park, Seung-Hyun Ko, Yu Wang
    PLoS ONE.2014; 9(10): e109878.     CrossRef
  • The Relationship between BMI and Glycated Albumin to Glycated Hemoglobin (GA/A1c) Ratio According to Glucose Tolerance Status
    Ji Hye Huh, Kwang Joon Kim, Byung-Wan Lee, Dong Wook Kim, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Marta Letizia Hribal
    PLoS ONE.2014; 9(2): e89478.     CrossRef
  • Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c
    Ja Young Jeon, Seung-Hyun Ko, Hyuk-Sang Kwon, Nan Hee Kim, Jae Hyeon Kim, Chul Sik Kim, Kee-Ho Song, Jong Chul Won, Soo Lim, Sung Hee Choi, Myoung-jin Jang, Yuna Kim, Kyungwon Oh, Dae Jung Kim, Bong-Yun Cha
    Diabetes & Metabolism Journal.2013; 37(5): 349.     CrossRef
  • Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients
    Dong-Lim Kim
    Diabetes & Metabolism Journal.2013; 37(6): 429.     CrossRef
  • Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
    Young Ki Lee, Sun Ok Song, Kwang Joon Kim, Yongin Cho, Younjeong Choi, Yujung Yun, Byung-Wan Lee, Eun-Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Diabetes & Metabolism Journal.2013; 37(6): 465.     CrossRef
  • Long-term changes of the prevalence and control rate of hypertension among Korean adults with diagnosed diabetes: 1998–2008 Korean National Health and Nutrition Examination Survey
    Seung-Hyun Ko, Hyuk-Sang Kwon, Ki-Ho Song, Yu-Bae Ahn, Kun-Ho Yoon, Hyeon Woo Yim, Won-Chul Lee, Yong-Moon Park
    Diabetes Research and Clinical Practice.2012; 97(1): 151.     CrossRef
  • Smoking and Type 2 Diabetes Mellitus
    Sang Ah Chang
    Diabetes & Metabolism Journal.2012; 36(6): 399.     CrossRef
  • Body Mass Index and Waist Circumference According to Glucose Tolerance Status in Korea: The 2005 Korean Health and Nutrition Examination Survey
    Hye Mi Kang, Dong-Jun Kim
    Journal of Korean Medical Science.2012; 27(5): 518.     CrossRef
  • Renal Hyperfiltration in Prediabetes Confirmed by Fasting Plasma Glucose and Hemoglobin A1c
    Rieko Okada, Kenji Wakai, Mariko Naito, Emi Morita, Sayo Kawai, Guang Yin, Noriyo Ozawa, Masatoshi Furuta, Erina Koyama, Rumi Tsuchiya, Noriko Kouno, Nobuyuki Hamajima
    Renal Failure.2012; 34(9): 1084.     CrossRef
  • Higher Morning to Evening Ratio in Total Dose of Twice-Daily Biphasic Insulin Analog Might Be Effective in Achieving Glucose Control in Patients with Poorly Controlled Type 2 Diabetes
    Yong-Ho Lee, Byung-Wan Lee, Hea Jin Kwon, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Diabetes Technology & Therapeutics.2012; 14(6): 508.     CrossRef
  • The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
    Sun Ok Song, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Diabetes & Metabolism Journal.2012; 36(5): 371.     CrossRef
  • Low Density Lipoprotein Cholesterol Target Goal Attainment Rate and Physician Perceptions about Target Goal Achievement in Korean Patients with Diabetes
    Jenie Yoonoo Hwang, Chang Hee Jung, Woo Je Lee, Cheol Young Park, Sung Rae Kim, Kun-Ho Yoon, Moon Kyu Lee, Sung Woo Park, Joong-Yeol Park
    Diabetes & Metabolism Journal.2011; 35(6): 628.     CrossRef
  • Letter: Diabetic Polyneuropathy and Cardiovascular Complications in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:390-6)
    Sun-Hye Ko, Seung-Hyun Ko
    Diabetes & Metabolism Journal.2011; 35(5): 558.     CrossRef
Understanding the Cardiovascular Effects of Incretin
Ji Sung Yoon, Hyoung Woo Lee
Diabetes Metab J. 2011;35(5):437-443.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.437
  • 3,495 View
  • 43 Download
  • 17 Crossref
AbstractAbstract PDFPubReader   

Cardiovascular disease (CVD), a leading cause of death in patients with diabetes mellitus, has several pathogenic mechanisms that are well established. However, the traditional hypoglycemic agents do not have proven positive effects on macrovascular disease. Novel therapeutic agents target the incretin pathway including the glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) agonists and the dipeptidyl peptidase-4 inhibitors. The glucose-regulatory actions of these agents function by increasing insulin secretion and suppressing glucagon. They also act to increase weight loss not only by inhibiting gastric emptying, but also by reducing appetite. Although GLP-1 and GLP-1R agonists have demonstrated beneficial effects on myocardium and vascular endothelium including coronary and peripheral mouse vessels, they also have anti-inflammatory and anti-atherogenic actions. These agents also have positive effects on the lipid profile and blood pressure. Although these cardioprotective actions seem to be beyond the effects of glucose control and weight loss, they are mediated through GLP-1R- or GLP-1R-independent actions of cleaved GLP-1 (9-36). Larger randomized controlled trials are necessary to elucidate the clinical promise of these beneficial CVD effects.

Citations

Citations to this article as recorded by  
  • Cardioprotective Effects of Glucagon-like Peptide-1 (9-36) Against Oxidative Injury in H9c2 Cardiomyoblasts: Potential Role of the PI3K/Akt/NOS Pathway
    Narawat Nuamnaichati, Warisara Parichatikanond, Supachoke Mangmool
    Journal of Cardiovascular Pharmacology.2022; 79(1): e50.     CrossRef
  • Comparisons of pleiotropic effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction
    Belma Turan, Aysegul Durak, Yusuf Olgar, Erkan Tuncay
    Molecular and Cellular Biochemistry.2022; 477(11): 2609.     CrossRef
  • Interrelations of components of metabolic syndrome with the level of the hormones involved in regulation of adipose tissue metabolism
    A. Y. Babenko, G. A. Matveev, T. I. Alekseenko, I. V. Derevitskii, M. A. Kokina, E. V. Shlyakhto
    "Arterial’naya Gipertenziya" ("Arterial Hypertension").2020; 25(6): 639.     CrossRef
  • Attenuation of carotid neointimal formation after direct delivery of a recombinant adenovirus expressing glucagon-like peptide-1 in diabetic rats
    Soo Lim, Gha Young Lee, Ho Seon Park, Dong-Hwa Lee, Oh Tae Jung, Kim Kyoung Min, Young-Bum Kim, Hee-Sook Jun, Jang Hak Chul, Kyong Soo Park
    Cardiovascular Research.2017; 113(2): 183.     CrossRef
  • Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
    Cristina Mega, Edite Teixeira-de-Lemos, Rosa Fernandes, Flávio Reis
    Journal of Diabetes Research.2017; 2017: 1.     CrossRef
  • Letter: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J2015;39:74-81)
    Hannah Seok
    Diabetes & Metabolism Journal.2015; 39(2): 171.     CrossRef
  • Diuretic and Natriuretic Effects of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin
    Masao Moroi, Tetsuya Kubota
    Journal of Cardiovascular Pharmacology.2015; 66(2): 159.     CrossRef
  • The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
    Na-Hyung Kim, Taeyang Yu, Dae Ho Lee
    BioMed Research International.2014; 2014: 1.     CrossRef
  • Tolerability, effectiveness and predictive parameters for the therapeutic usefulness of exenatide in obese, Korean patients with type 2 diabetes
    Sun Ok Song, Kwang Joon Kim, Byung‐Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Journal of Diabetes Investigation.2014; 5(5): 554.     CrossRef
  • The endothelium in diabetes: Its role in insulin access and diabetic complications
    Cathryn M. Kolka, Richard N. Bergman
    Reviews in Endocrine and Metabolic Disorders.2013; 14(1): 13.     CrossRef
  • Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?
    Lauren M Cornall, Michael L Mathai, Deanne H Hryciw, Andrew J McAinch
    Expert Opinion on Investigational Drugs.2013; 22(4): 487.     CrossRef
  • Effects of GLP-1 on Forearm Vasodilator Function and Glucose Disposal During Hyperinsulinemia in the Metabolic Syndrome
    Manfredi Tesauro, Francesca Schinzari, Angelo Adamo, Valentina Rovella, Francesca Martini, Nadia Mores, Angela Barini, Dario Pitocco, Giovanni Ghirlanda, Davide Lauro, Umberto Campia, Carmine Cardillo
    Diabetes Care.2013; 36(3): 683.     CrossRef
  • Effect of a Dipeptidyl Peptidase-IV Inhibitor, Des-Fluoro-Sitagliptin, on Neointimal Formation after Balloon Injury in Rats
    Soo Lim, Sung Hee Choi, Hayley Shin, Bong Jun Cho, Ho Seon Park, Byung Yong Ahn, Seon Mee Kang, Ji Won Yoon, Hak Chul Jang, Young-Bum Kim, Kyong Soo Park, Alice Y. W. Chang
    PLoS ONE.2012; 7(4): e35007.     CrossRef
  • Glucagon-like peptide 1 and cardiac cell survival
    Susana Ravassa, Amaia Zudaire, Javier Díez
    Endocrinología y Nutrición (English Edition).2012; 59(9): 561.     CrossRef
  • GLP-1 and cardioprotection: from bench to bedside
    S. Ravassa, A. Zudaire, J. Diez
    Cardiovascular Research.2012; 94(2): 316.     CrossRef
  • Saxagliptin improves glucose tolerance but not survival in a murine model of dilated cardiomyopathy
    Arpita Kalla Vyas, Lauren B. Aerni-Flessner, Maria A. Payne, Attila Kovacs, Patrick Y. Jay, Paul W. Hruz
    Cardiovascular Endocrinology.2012; 1(4): 74.     CrossRef
  • Péptido similar al glucagón tipo 1 y supervivencia de la célula cardiaca
    Susana Ravassa, Amaia Zudaire, Javier Díez
    Endocrinología y Nutrición.2012; 59(9): 561.     CrossRef
Glucolipotoxicity in Pancreatic β-Cells
Ji-Won Kim, Kun-Ho Yoon
Diabetes Metab J. 2011;35(5):444-450.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.444
  • 54,775 View
  • 102 Download
  • 59 Crossref
AbstractAbstract PDFPubReader   

The recent epidemic of type 2 diabetes in Asia differs from that reported in other regions of the world in several key areas: it has evolved over a much shorter time, in an earlier stage of life, and in people with lower body mass indices. These phenotypic characteristics of patients strongly suggest that insulin secretory defects may perform a more important function in the development and progression of diabetes. A genetic element clearly underlies β-cell dysfunction and insufficient β-cell mass; however, a number of modifiable factors are also linked to β-cell deterioration, most notably chronic hyperglycemia and elevated free fatty acid (FFA) levels. Neither glucose nor FFAs alone cause clinically meaningful β-cell toxicity, especially in patients with normal or impaired glucose tolerance. Thus the term "glucolipotoxicity" is perhaps more appropriate in describing the phenomenon. Several mechanisms have been proposed to explain glucolipotoxicity-induced β-cell dysfunction and death, but its major factors appear to be depression of key transcription factor gene expression by altered intracellular energy metabolism and oxidative stress. Therefore, stabilization of metabolic changes induced by glucolipotoxicity in β-cells represents a new avenue for the treatment of type 2 diabetes mellitus.

Citations

Citations to this article as recorded by  
  • Intravoxel incoherent motion diffusion-weighted imaging of pancreas: Probing evidence of β-cell dysfunction in asymptomatic adults with hyperglycemia in vivo
    Yingying Song, Bo Chen, Kejing Zeng, Kejia Cai, Hui Sun, Deqing Liu, Ping Liu, Gugen Xu, Guihua Jiang
    Magnetic Resonance Imaging.2024; 108: 161.     CrossRef
  • PIMT Controls Insulin Synthesis and Secretion through PDX1
    Rahul Sharma, Sujay K. Maity, Partha Chakrabarti, Madhumohan R. Katika, Satyamoorthy Kapettu, Kishore V. L. Parsa, Parimal Misra
    International Journal of Molecular Sciences.2023; 24(9): 8084.     CrossRef
  • Growth differentiation factor-15 prevents glucotoxicity and connexin-36 downregulation in pancreatic beta-cells
    Mohamed Asrih, Rodolphe Dusaulcy, Yvan Gosmain, Jacques Philippe, Emmanuel Somm, François R. Jornayvaz, Baeki E. Kang, Yunju Jo, Min Jeong Choi, Hyon-Seung Yi, Dongryeol Ryu, Karim Gariani
    Molecular and Cellular Endocrinology.2022; 541: 111503.     CrossRef
  • Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives
    Jasvinder Singh Bhatti, Abhishek Sehrawat, Jayapriya Mishra, Inderpal Singh Sidhu, Umashanker Navik, Naina Khullar, Shashank Kumar, Gurjit Kaur Bhatti, P. Hemachandra Reddy
    Free Radical Biology and Medicine.2022; 184: 114.     CrossRef
  • Phenotypic Screening for Small Molecules that Protect β-Cells from Glucolipotoxicity
    Jonnell C. Small, Aidan Joblin-Mills, Kaycee Carbone, Maria Kost-Alimova, Kumiko Ayukawa, Carol Khodier, Vlado Dancik, Paul A. Clemons, Andrew B. Munkacsi, Bridget K. Wagner
    ACS Chemical Biology.2022; 17(5): 1131.     CrossRef
  • Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management
    Svetlana Dinić, Jelena Arambašić Jovanović, Aleksandra Uskoković, Mirjana Mihailović, Nevena Grdović, Anja Tolić, Jovana Rajić, Marija Đorđević, Melita Vidaković
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Targeting pancreatic β cells for diabetes treatment
    Chirag Jain, Ansarullah, Sara Bilekova, Heiko Lickert
    Nature Metabolism.2022; 4(9): 1097.     CrossRef
  • The high-fructose intake of dams during pregnancy and lactation exerts sex-specific effects on adult rat offspring metabolism
    Francisca A. Tobar-Bernal, Sergio R. Zamudio, Lucía Quevedo-Corona
    Journal of Developmental Origins of Health and Disease.2021; 12(3): 411.     CrossRef
  • Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies
    Safia Costes, Gyslaine Bertrand, Magalie A. Ravier
    International Journal of Molecular Sciences.2021; 22(10): 5303.     CrossRef
  • A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives
    Josh Reed, Stephen Bain, Venkateswarlu Kanamarlapudi
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 3567.     CrossRef
  • Beta-Cell Dysfunction Induced by Tacrolimus: A Way to Explain Type 2 Diabetes?
    Ana Elena Rodriguez-Rodriguez, Esteban Porrini, Armando Torres
    International Journal of Molecular Sciences.2021; 22(19): 10311.     CrossRef
  • Involvement of Metabolic Lipid Mediators in the Regulation of Apoptosis
    Piotr Wójcik, Neven Žarković, Agnieszka Gęgotek, Elżbieta Skrzydlewska
    Biomolecules.2020; 10(3): 402.     CrossRef
  • Phytochemicals as modulators of β-cells and immunity for the therapy of type 1 diabetes: Recent discoveries in pharmacological mechanisms and clinical potential
    Maria Karmella Apaya, Tien-Fen Kuo, Meng-Ting Yang, Greta Yang, Chiao-Ling Hsiao, Song-Bin Chang, Yenshou Lin, Wen-Chin Yang
    Pharmacological Research.2020; 156: 104754.     CrossRef
  • Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases
    Waihong Chung, Kittichai Promrat, Jack Wands
    World Journal of Hepatology.2020; 12(9): 533.     CrossRef
  • Mitochondrial GTP Links Nutrient Sensing to β Cell Health, Mitochondrial Morphology, and Insulin Secretion Independent of OxPhos
    Sean R. Jesinkey, Anila K. Madiraju, Tiago C. Alves, OrLando H. Yarborough, Rebecca L. Cardone, Xiaojian Zhao, Yassmin Parsaei, Ali R. Nasiri, Gina Butrico, Xinran Liu, Anthony J. Molina, Austin M. Rountree, Adam S. Neal, Dane M. Wolf, John Sterpka, Willi
    Cell Reports.2019; 28(3): 759.     CrossRef
  • Metabolic signatures suggest o-phosphocholine to UDP-N-acetylglucosamine ratio as a potential biomarker for high-glucose and/or palmitate exposure in pancreatic β-cells
    Saleem Yousf, Devika M. Sardesai, Abraham B. Mathew, Rashi Khandelwal, Jhankar D. Acharya, Shilpy Sharma, Jeetender Chugh
    Metabolomics.2019;[Epub]     CrossRef
  • Glucolipotoxicity Alters Insulin Secretion via Epigenetic Changes in Human Islets
    Elin Hall, Josefine Jönsson, Jones K. Ofori, Petr Volkov, Alexander Perfilyev, Marloes Dekker Nitert, Lena Eliasson, Charlotte Ling, Karl Bacos
    Diabetes.2019; 68(10): 1965.     CrossRef
  • Bioinformatic analysis of peripheral blood RNA-sequencing sensitively detects the cause of late graft loss following overt hyperglycemia in pig-to-nonhuman primate islet xenotransplantation
    Hyun-Je Kim, Ji Hwan Moon, Hyunwoo Chung, Jun-Seop Shin, Bongi Kim, Jong-Min Kim, Jung-Sik Kim, Il-Hee Yoon, Byoung-Hoon Min, Seong-Jun Kang, Yong-Hee Kim, Kyuri Jo, Joungmin Choi, Heejoon Chae, Won-Woo Lee, Sun Kim, Chung-Gyu Park
    Scientific Reports.2019;[Epub]     CrossRef
  • Centaurium erythraea extract improves survival and functionality of pancreatic beta-cells in diabetes through multiple routes of action
    Miloš Đorđević, Nevena Grdović, Mirjana Mihailović, Jelena Arambašić Jovanović, Aleksandra Uskoković, Jovana Rajić, Marija Sinadinović, Anja Tolić, Danijela Mišić, Branislav Šiler, Goran Poznanović, Melita Vidaković, Svetlana Dinić
    Journal of Ethnopharmacology.2019; 242: 112043.     CrossRef
  • Caveolin-1 deficiency protects pancreatic β cells against palmitate-induced dysfunction and apoptosis
    Wen Zeng, Jiansong Tang, Haicheng Li, Haixia Xu, Hongyun Lu, Hangya Peng, Chuwen Lin, Rili Gao, Shuo Lin, Keyi Lin, Kunying Liu, Yan Jiang, Jianping Weng, Longyi Zeng
    Cellular Signalling.2018; 47: 65.     CrossRef
  • Temporal Proteomic Analysis of Pancreatic β-Cells in Response to Lipotoxicity and Glucolipotoxicity
    Zonghong Li, Hongyang Liu, Zhangjing Niu, Wen Zhong, Miaomiao Xue, Jifeng Wang, Fuquan Yang, Yue Zhou, Yifa Zhou, Tao Xu, Junjie Hou
    Molecular & Cellular Proteomics.2018; 17(11): 2119.     CrossRef
  • Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass
    Blandine Laferrère, François Pattou
    Frontiers in Endocrinology.2018;[Epub]     CrossRef
  • Effects of moderate exercise on biochemical, morphological, and physiological parameters of the pancreas of female mice with estrogen deprivation and dyslipidemia
    Aparecida Gabriela Bexiga Veloso, Nathalia Edviges Alves Lima, Elisabete de Marco Ornelas, Clever Gomes Cardoso, Mara Rubia Marques, Beatriz da Costa Aguiar Alves Reis, Fernando Luiz Affonso Fonseca, Laura Beatriz Mesiano Maifrino
    Medical Molecular Morphology.2018; 51(2): 118.     CrossRef
  • Cardiac Glucolipotoxicity and Cardiovascular Outcomes
    Marlon E. Cerf
    Medicina.2018; 54(5): 70.     CrossRef
  • High frequency of type 2 diabetes and impaired glucose tolerance in Japanese subjects with the angiopoietin-like protein 8 R59W variant
    Jianhui Liu, Kunimasa Yagi, Atsushi Nohara, Daisuke Chujo, Azusa Ohbatake, Aya Fujimoto, Yukiko Miyamoto, Junji Kobayashi, Masakazu Yamagishi
    Journal of Clinical Lipidology.2018; 12(2): 331.     CrossRef
  • Identification of Digestive Enzyme Inhibitors from Ludwigia octovalvis (Jacq.) P.H.Raven
    Dulce Morales, Guillermo Ramirez, Armando Herrera-Arellano, Jaime Tortoriello, Miguel Zavala, Alejandro Zamilpa
    Evidence-Based Complementary and Alternative Medicine.2018; 2018: 1.     CrossRef
  • The impairment of glucose-stimulated insulin secretion in pancreatic β-cells caused by prolonged glucotoxicity and lipotoxicity is associated with elevated adaptive antioxidant response
    Jingqi Fu, Qi Cui, Bei Yang, Yongyong Hou, Huihui Wang, Yuanyuan Xu, Difei Wang, Qiang Zhang, Jingbo Pi
    Food and Chemical Toxicology.2017; 100: 161.     CrossRef
  • Phenolic constituents and modulatory effects of Raffia palm leaf ( Raphia hookeri ) extract on carbohydrate hydrolyzing enzymes linked to type-2 diabetes
    Felix A. Dada, Sunday I. Oyeleye, Opeyemi B. Ogunsuyi, Tosin A. Olasehinde, Stephen A. Adefegha, Ganiyu Oboh, Aline A. Boligon
    Journal of Traditional and Complementary Medicine.2017; 7(4): 494.     CrossRef
  • A gene-environment interaction analysis of plasma selenium with prevalent and incident diabetes: The Hortega study
    Inmaculada Galan-Chilet, Maria Grau-Perez, Griselda De Marco, Eliseo Guallar, Juan Carlos Martin-Escudero, Alejandro Dominguez-Lucas, Isabel Gonzalez-Manzano, Raul Lopez-Izquierdo, Laisa Socorro Briongos-Figuero, Josep Redon, Felipe Javier Chaves, Maria T
    Redox Biology.2017; 12: 798.     CrossRef
  • Differential dose-dependent Effects of Zinc Oxide Nanoparticles on Oxidative stress-mediated Pancreatic β-cell Death
    Swati C Asani, Rinku D Umrani, Kishore M Paknikar
    Nanomedicine.2017; 12(7): 745.     CrossRef
  • Mild hyperglycemia triggered islet function recovery in streptozotocin‐induced insulin‐deficient diabetic rats
    Yu Cheng, Jing Shen, Weizheng Ren, Haojie Hao, Zongyan Xie, Jiejie Liu, Yiming Mu, Weidong Han
    Journal of Diabetes Investigation.2017; 8(1): 44.     CrossRef
  • The Novel Mechanisms Concerning the Inhibitions of Palmitate-Induced Proinflammatory Factor Releases and Endogenous Cellular Stress with Astaxanthin on MIN6 β-Cells
    Atsuko Kitahara, Kazuto Takahashi, Naru Morita, Toshitaka Murashima, Hirohisa Onuma, Yoshikazu Sumitani, Toshiaki Tanaka, Takuma Kondo, Toshio Hosaka, Hitoshi Ishida
    Marine Drugs.2017; 15(6): 185.     CrossRef
  • Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice
    Esther Nuñez-Durán, Belén Chanclón, Silva Sütt, Joana Real, Hanns-Ulrich Marschall, Ingrid Wernstedt Asterholm, Emmelie Cansby, Margit Mahlapuu
    Journal of Endocrinology.2017; 234(1): 15.     CrossRef
  • Metformin prevents glucotoxicity by alleviating oxidative and ER stress–induced CD36 expression in pancreatic beta cells
    Jun Sung Moon, Udayakumar Karunakaran, Suma Elumalai, In-Kyu Lee, Hyoung Woo Lee, Yong-Woon Kim, Kyu Chang Won
    Journal of Diabetes and its Complications.2017; 31(1): 21.     CrossRef
  • The Glucotoxicity Protecting Effect of Ezetimibe in Pancreatic Beta Cells via Inhibition of CD36
    Ji Sung Yoon, Jun Sung Moon, Yong-Woon Kim, Kyu Chang Won, Hyoung Woo Lee
    Journal of Korean Medical Science.2016; 31(4): 547.     CrossRef
  • The level of netrin-1 is decreased in newly diagnosed type 2 diabetes mellitus patients
    Chenxiao Liu, Xianjin Ke, Ying Wang, Xiu Feng, Qi Li, Ying Zhang, Jian Zhu, Qian Li
    BMC Endocrine Disorders.2016;[Epub]     CrossRef
  • Liraglutide Compromises Pancreatic β Cell Function in a Humanized Mouse Model
    Midhat H. Abdulreda, Rayner Rodriguez-Diaz, Alejandro Caicedo, Per-Olof Berggren
    Cell Metabolism.2016; 23(3): 541.     CrossRef
  • Glucolipotoxicity diminishes cardiomyocyte TFEB and inhibits lysosomal autophagy during obesity and diabetes
    Purvi C. Trivedi, Jordan J. Bartlett, Lester J. Perez, Keith R. Brunt, Jean Francois Legare, Ansar Hassan, Petra C. Kienesberger, Thomas Pulinilkunnil
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2016; 1861(12): 1893.     CrossRef
  • Diabetes risk prediction model for non‐obese Asian Indians residing in North India using cut‐off values for pancreatic and intra‐abdominal fat volume and liver span
    Shajith Anoop, Anoop Misra, Kalaivani Mani, Ravindra Mohan Pandey, Seema Gulati
    Journal of Diabetes.2016; 8(5): 729.     CrossRef
  • Identifying crop variants with high resistant starch content to maintain healthy glucose homeostasis
    K. Petropoulou, E. S. Chambers, D. J. Morrison, T. Preston, I. F. Godsland, P. Wilde, A. Narbad, R. Parker, L. Salt, V. J. Morris, C. Domoney, S. J. Persaud, E. Holmes, S. Penson, J. Watson, M. Stocks, M. Buurman, M. Luterbacher, G. Frost
    Nutrition Bulletin.2016; 41(4): 372.     CrossRef
  • Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets
    CHENGHU HUANG, LI YUAN, SHUYI CAO
    International Journal of Molecular Medicine.2015; 36(1): 173.     CrossRef
  • Mitochondrien als Kraftwerk der β-Zelle
    S. Baltrusch, F. Reinhardt, M. Tiedge
    Der Diabetologe.2015; 11(3): 231.     CrossRef
  • Protein-Binding Function of RNA-Dependent Protein Kinase Promotes Proliferation through TRAF2/RIP1/NF-κB/c-Myc Pathway in Pancreatic β cells
    LiLi Gao, Wei Tang, ZhengZheng Ding, DingYu Wang, XiaoQiang Qi, HuiWen Wu, Jun Guo
    Molecular Medicine.2015; 21(1): 154.     CrossRef
  • Phosphorylation of caveolin-1 on tyrosine-14 induced by ROS enhances palmitate-induced death of beta-pancreatic cells
    Sergio Wehinger, Rina Ortiz, María Inés Díaz, Adam Aguirre, Manuel Valenzuela, Paola Llanos, Christopher Mc Master, Lisette Leyton, Andrew F.G. Quest
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2015; 1852(5): 693.     CrossRef
  • Body Fat Patterning, Hepatic Fat and Pancreatic Volume of Non-Obese Asian Indians with Type 2 Diabetes in North India: A Case-Control Study
    Anoop Misra, Shajith Anoop, Seema Gulati, Kalaivani Mani, Surya Prakash Bhatt, Ravindra Mohan Pandey, Anna Alisi
    PLOS ONE.2015; 10(10): e0140447.     CrossRef
  • CD36 initiated signaling mediates ceramide-induced TXNIP expression in pancreatic beta-cells
    Udayakumar Karunakaran, Jun Sung Moon, Hyoung Woo Lee, Kyu Chang Won
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2015; 1852(11): 2414.     CrossRef
  • Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1
    Mark F McCarty, James J DiNicolantonio
    Open Heart.2015; 2(1): e000205.     CrossRef
  • Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes
    James J DiNicolantonio, Jaikrit Bhutani, James H O'Keefe
    Open Heart.2015; 2(1): e000327.     CrossRef
  • P38 Plays an Important Role in Glucolipotoxicity-Induced Apoptosis in INS-1 Cells
    Lingli Zhou, Xiaoling Cai, Xueyao Han, Linong Ji
    Journal of Diabetes Research.2014; 2014: 1.     CrossRef
  • ImpairedβCell Function in Chinese Newly Diagnosed Type 2 Diabetes Mellitus with Hyperlipidemia
    Yuhang Ma, Yufan Wang, Qianfang Huang, Qian Ren, Su Chen, Aifang Zhang, Li Zhao, Qin Zhen, Yongde Peng
    Journal of Diabetes Research.2014; 2014: 1.     CrossRef
  • Type 2 Diabetes, PUFAs, and Vitamin D: Their Relation to Inflammation
    Ana L. Guadarrama-López, Roxana Valdés-Ramos, Beatríz E. Martínez-Carrillo
    Journal of Immunology Research.2014; 2014: 1.     CrossRef
  • A Comparative Study of the Effects of a Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability in Patients with Type 2 Diabetes with Inadequate Glycemic Control on Metformin
    Hun-Sung Kim, Jeong-Ah Shin, Seung-Hwan Lee, Eun-Sook Kim, Jae-Hyoung Cho, Ho-Young Son, Kun-Ho Yoon
    Diabetes Technology & Therapeutics.2013; 15(10): 810.     CrossRef
  • Localization and regulation of pancreatic selenoprotein P
    Holger Steinbrenner, Anna-Lena Hotze, Bodo Speckmann, Antonio Pinto, Helmut Sies, Matthias Schott, Margret Ehlers, Werner A Scherbaum, Sven Schinner
    Journal of Molecular Endocrinology.2013; 50(1): 31.     CrossRef
  • Glycated Albumin Causes Pancreatic β-Cells Dysfunction Through Autophagy Dysfunction
    Young Mi Song, Sun Ok Song, Young-Hye You, Kun-Ho Yoon, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Ji-Won Kim, Byung-Wan Lee
    Endocrinology.2013; 154(8): 2626.     CrossRef
  • miRNA-30a-5p-mediated silencing of Beta2/NeuroD expression is an important initial event of glucotoxicity-induced beta cell dysfunction in rodent models
    J.-W. Kim, Y.-H. You, S. Jung, H. Suh-Kim, I.-K. Lee, J.-H. Cho, K.-H. Yoon
    Diabetologia.2013; 56(4): 847.     CrossRef
  • Investigating Endothelial Activation and Oxidative Stress in relation to Glycaemic Control in a Multiethnic Population
    E. M. Brady, D. R. Webb, D. H. Morris, K. Khunti, D. S. C. Talbot, N. Sattar, M. J. Davies
    Experimental Diabetes Research.2012; 2012: 1.     CrossRef
  • Inhibition of fatty acid translocase cluster determinant 36 (CD36), stimulated by hyperglycemia, prevents glucotoxicity in INS-1 cells
    Yong-Woon Kim, Jun Sung Moon, Ye Jin Seo, So-Young Park, Jong-Yeon Kim, Ji Sung Yoon, In-Kyu Lee, Hyoung Woo Lee, Kyu Chang Won
    Biochemical and Biophysical Research Communications.2012; 420(2): 462.     CrossRef
  • Human Monoclonal Antibodies against Glucagon Receptor Improve Glucose Homeostasis by Suppression of Hepatic Glucose Output in Diet-Induced Obese Mice
    Wook-Dong Kim, Yong-ho Lee, Min-Hee Kim, Sun-Young Jung, Woo-Chan Son, Seon-Joo Yoon, Byung-Wan Lee, Nigel Irwin
    PLoS ONE.2012; 7(12): e50954.     CrossRef
  • Understanding Pancreas Development for β-Cell Repair and Replacement Therapies
    Aurelia Raducanu, Heiko Lickert
    Current Diabetes Reports.2012; 12(5): 481.     CrossRef
The Role of the Sweet Taste Receptor in Enteroendocrine Cells and Pancreatic β-Cells
Itaru Kojima, Yuko Nakagawa
Diabetes Metab J. 2011;35(5):451-457.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.451
  • 4,541 View
  • 88 Download
  • 45 Crossref
AbstractAbstract PDFPubReader   

The sweet taste receptor is expressed in taste cells located in taste buds of the tongue. This receptor senses sweet substances in the oral cavity, activates taste cells, and transmits the taste signals to adjacent neurons. The sweet taste receptor is a heterodimer of two G protein-coupled receptors, T1R2 and T1R3. Recent studies have shown that this receptor is also expressed in the extragustatory system, including the gastrointestinal tract, pancreatic β-cells, and glucose-responsive neurons in the brain. In the intestine, the sweet taste receptor regulates secretion of incretin hormones and glucose uptake from the lumen. In β-cells, activation of the sweet taste receptor leads to stimulation of insulin secretion. Collectively, the sweet taste receptor plays an important role in recognition and metabolism of energy sources in the body.

Citations

Citations to this article as recorded by  
  • Targeting T2Rs, a feasible approach for natural bitter agents from traditional Chinese medicine modulate ABC transporters to treat respiratory diseases
    Qi Liang, Ruo-Lan Li, Dan-Dan Tang, Ting Zhang, Lian Zhong, Chun-Jie Wu, Wei Peng
    Arabian Journal of Chemistry.2024; 17(1): 105377.     CrossRef
  • Impact of dietary sucralose and sucrose-sweetened water intake on lipid and glucose metabolism in male mice
    Xinyi Wu, Le Cui, Haoquan Wang, Jinhong Xu, Zhaozhao Zhong, Xibei Jia, Jiaqi Wang, Huahua Zhang, Yanteng Shi, Yuhang Tang, Qianhui Yang, Qiongdan Liang, Yujing Zhang, Jing Li, Xiaohong Jiang
    European Journal of Nutrition.2023; 62(1): 199.     CrossRef
  • How dietary amino acids and high protein diets influence insulin secretion
    Yuuki Yanagisawa
    Physiological Reports.2023;[Epub]     CrossRef
  • The elusive cephalic phase insulin response: triggers, mechanisms, and functions
    Wolfgang Langhans, Alan G. Watts, Alan C. Spector
    Physiological Reviews.2023; 103(2): 1423.     CrossRef
  • Trace Amine-Associated Receptors and Monoamine-Mediated Regulation of Insulin Secretion in Pancreatic Islets
    Anastasia N. Vaganova, Taisiia S. Shemyakova, Karina V. Lenskaia, Roman N. Rodionov, Charlotte Steenblock, Raul R. Gainetdinov
    Biomolecules.2023; 13(11): 1618.     CrossRef
  • Gene expression analyses of TAS1R taste receptors relevant to the treatment of cardiometabolic disease
    Mariah R Stavrou, Sean Souchiart So, Angela M Finch, Sara Ballouz, Nicola J Smith
    Chemical Senses.2023;[Epub]     CrossRef
  • Dysgeusia
    Davis C. Thomas, Deepti Chablani, Srishti Parekh, Reshmy Chellam Pichammal, Karpagavalli Shanmugasundaram, Priyanka Kodaganallur Pitchumani
    The Journal of the American Dental Association.2022; 153(3): 251.     CrossRef
  • Oral Microbiota-Host Interaction Mediated by Taste Receptors
    Hao Dong, Jiaxin Liu, Jianhui Zhu, Zhiyan Zhou, Marco Tizzano, Xian Peng, Xuedong Zhou, Xin Xu, Xin Zheng
    Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
  • New frontiers in the hunger management involving GLP‐1, taste and oestrogen
    Maja Baretić
    Diabetic Medicine.2022;[Epub]     CrossRef
  • The Impact of Artificial Sweeteners on Body Weight Control and Glucose Homeostasis
    Michelle D. Pang, Gijs H. Goossens, Ellen E. Blaak
    Frontiers in Nutrition.2021;[Epub]     CrossRef
  • TAS1R2 sweet taste receptor genetic variation and dietary intake in Korean females
    Jeong-Hwa Choi
    Appetite.2021; 164: 105281.     CrossRef
  • Sweet Taste Is Complex: Signaling Cascades and Circuits Involved in Sweet Sensation
    Elena von Molitor, Katja Riedel, Michael Krohn, Mathias Hafner, Rüdiger Rudolf, Tiziana Cesetti
    Frontiers in Human Neuroscience.2021;[Epub]     CrossRef
  • Hazardous Hyperglisemic Effect of Facial Ischemia Following Subarachnoid Hemorrhage: An Experimental Study
    Mehmet Dumlu Aydin, Ozgur Caglar, Mehmet Nuri Kocak, Erdem Karadeniz, Nazan Aydin, Irem Ates, Sevilay Ozmen
    Archives of Neuroscience.2020;[Epub]     CrossRef
  • Determinants of Sweetness Preference: A Scoping Review of Human Studies
    Carolina Venditti, Kathy Musa-Veloso, Han Youl Lee, Theresa Poon, Alastair Mak, Maryse Darch, Justine Juana, Dylan Fronda, Daniel Noori, Erika Pateman, Maia Jack
    Nutrients.2020; 12(3): 718.     CrossRef
  • Allelic variation of the Tas1r3 taste receptor gene affects sweet taste responsiveness and metabolism of glucose in F1 mouse hybrids
    Vladimir O. Murovets, Ekaterina A. Lukina, Egor A. Sozontov, Julia V. Andreeva, Raisa P. Khropycheva, Vasiliy A. Zolotarev, Keiko Abe
    PLOS ONE.2020; 15(7): e0235913.     CrossRef
  • Effect of sucralose and aspartame on glucose metabolism and gut hormones
    Samar Y Ahmad, James K Friel, Dylan S Mackay
    Nutrition Reviews.2020; 78(9): 725.     CrossRef
  • Maternal low protein exposure alters glucose tolerance and intestinal nutrient-responsive receptors and transporters expression of rat offspring
    Nan Wang, Bo Lv, Limin Guan, Hu Qiao, Bo Sun, Xiao Luo, Ru Jia, Ke Chen, Jianqun Yan
    Life Sciences.2020; 243: 117216.     CrossRef
  • Sugar Reduction in Dairy Food: An Overview with Flavoured Milk as an Example
    Dipendra Kumar Mahato, Russell Keast, Djin Gie Liem, Catherine Georgina Russell, Sara Cicerale, Shirani Gamlath
    Foods.2020; 9(10): 1400.     CrossRef
  • Electrophysiology of the pancreatic islet β-cell sweet taste receptor TIR3
    Juan V. Sanchez-Andres, Willy J. Malaisse, Itaru Kojima
    Pflügers Archiv - European Journal of Physiology.2019; 471(4): 647.     CrossRef
  • A Single 48 mg Sucralose Sip Unbalances Monocyte Subpopulations and Stimulates Insulin Secretion in Healthy Young Adults
    Angélica Y. Gómez-Arauz, Nallely Bueno-Hernández, Leon F. Palomera, Raúl Alcántara-Suárez, Karen L. De León, Lucía A. Méndez-García, Miguel Carrero-Aguirre, Aaron N. Manjarrez-Reyna, Camilo P. Martínez-Reyes, Marcela Esquivel-Velázquez, Alejandra Ruiz-Bar
    Journal of Immunology Research.2019; 2019: 1.     CrossRef
  • Sugar reduction without compromising sensory perception. An impossible dream?
    Scott C. Hutchings, Julia Y. Q. Low, Russell S. J. Keast
    Critical Reviews in Food Science and Nutrition.2019; 59(14): 2287.     CrossRef
  • Oral and Post‐Oral Actions of Low‐Calorie Sweeteners: A Tale of Contradictions and Controversies
    John I. Glendinning
    Obesity.2018;[Epub]     CrossRef
  • Olfactory, Taste, and Photo Sensory Receptors in Non-sensory Organs: It Just Makes Sense
    Nicholas M. Dalesio, Sebastian F. Barreto Ortiz, Jennifer L. Pluznick, Dan E. Berkowitz
    Frontiers in Physiology.2018;[Epub]     CrossRef
  • Emerging Concepts in Brain Glucose Metabolic Functions: From Glucose Sensing to How the Sweet Taste of Glucose Regulates Its Own Metabolism in Astrocytes and Neurons
    Menizibeya O. Welcome, Nikos E. Mastorakis
    NeuroMolecular Medicine.2018; 20(3): 281.     CrossRef
  • Anti-diabetic effects of natural products an overview of therapeutic strategies
    Jiyoung Park, Hyeung-Jin Jang
    Molecular & Cellular Toxicology.2017; 13(1): 1.     CrossRef
  • Natural sweetener agave inhibits gastric emptying in rats by a cholecystokinin-2- and glucagon like peptide-1 receptor-dependent mechanism
    E. Bihter Gürler, Dilek Özbeyli, Hülya Buzcu, Sezin Bayraktar, İrem Carus, Beyza Dağ, Yasemin Geriş, Seda Jeral, Berrak Ç. Yeğen
    Food & Function.2017; 8(2): 741.     CrossRef
  • T1R3 homomeric sweet taste receptor regulates adipogenesis through Gαs-mediated microtubules disassembly and Rho activation in 3T3-L1 cells
    Yosuke Masubuchi, Yuko Nakagawa, Johan Medina, Masahiro Nagasawa, Itaru Kojima, Mark M. Rasenick, Takeshi Inagaki, Hiroshi Shibata, Hiroaki Matsunami
    PLOS ONE.2017; 12(5): e0176841.     CrossRef
  • Hormonal responses to non-nutritive sweeteners in water and diet soda
    Allison C. Sylvetsky, Rebecca J. Brown, Jenny E. Blau, Mary Walter, Kristina I. Rother
    Nutrition & Metabolism.2016;[Epub]     CrossRef
  • Gastrointestinal defense mechanisms
    Hyder Said, Jonathan D. Kaunitz
    Current Opinion in Gastroenterology.2016; 32(6): 461.     CrossRef
  • Glucose-Sensing Receptor T1R3: A New Signaling Receptor Activated by Glucose in Pancreatic β-Cells
    Itaru Kojima, Yuko Nakagawa, Kunihisa Hamano, Johan Medina, Longfei Li, Masahiro Nagasawa
    Biological & Pharmaceutical Bulletin.2015; 38(5): 674.     CrossRef
  • Impaired Glucose Metabolism in Mice Lacking the Tas1r3 Taste Receptor Gene
    Vladimir O. Murovets, Alexander A. Bachmanov, Vasiliy A. Zolotarev, Hiroaki Matsunami
    PLOS ONE.2015; 10(6): e0130997.     CrossRef
  • Sweet Taste Receptor Signaling Network: Possible Implication for Cognitive Functioning
    Menizibeya O. Welcome, Nikos E. Mastorakis, Vladimir A. Pereverzev
    Neurology Research International.2015; 2015: 1.     CrossRef
  • Expression of the glucose-sensing receptor T1R3 in pancreatic islet: changes in the expression levels in various nutritional and metabolic states
    Anya Medina, Yuko Nakagawa, Jinhui Ma, Longfei Li, Kunihisa Hamano, Toshio Akimoto, Yuzo Ninomiya, Itaru Kojima
    Endocrine Journal.2014; 61(8): 797.     CrossRef
  • Normal Roles for Dietary Fructose in Carbohydrate Metabolism
    Maren Laughlin
    Nutrients.2014; 6(8): 3117.     CrossRef
  • Glucose promotes its own metabolism by acting on the cell-surface glucose-sensing receptor T1R3
    Yuko Nakagawa, Yoshiaki Ohtsu, Masahiro Nagasawa, Hiroshi Shibata, Itaru Kojima
    Endocrine Journal.2014; 61(2): 119.     CrossRef
  • Diverse signaling systems activated by the sweet taste receptor in human GLP-1-secreting cells
    Yoshiaki Ohtsu, Yuko Nakagawa, Masahiro Nagasawa, Shigeki Takeda, Hirokazu Arakawa, Itaru Kojima
    Molecular and Cellular Endocrinology.2014; 394(1-2): 70.     CrossRef
  • Sweet Taste-Sensing Receptors Expressed in Pancreatic β-Cells: Sweet Molecules Act as Biased Agonists
    Itaru Kojima, Yuko Nakagawa, Yoshiaki Ohtsu, Anya Medina, Masahiro Nagasawa
    Endocrinology and Metabolism.2014; 29(1): 12.     CrossRef
  • The Role of Sweet Taste in Satiation and Satiety
    Yu Low, Kathleen Lacy, Russell Keast
    Nutrients.2014; 6(9): 3431.     CrossRef
  • Insulin release: the receptor hypothesis
    Willy J. Malaisse
    Diabetologia.2014; 57(7): 1287.     CrossRef
  • The involvement of the T1R3 receptor protein in the control of glucose metabolism in mice at different levels of glycemia
    V. O. Murovets, A. A. Bachmanov, S. V. Travnikov, A. A. Churikova, V. A. Zolotarev
    Journal of Evolutionary Biochemistry and Physiology.2014; 50(4): 334.     CrossRef
  • GKAs for diabetes therapy: why no clinically useful drug after two decades of trying?
    Franz M. Matschinsky
    Trends in Pharmacological Sciences.2013; 34(2): 90.     CrossRef
  • A Novel Regulatory Function of Sweet Taste-Sensing Receptor in Adipogenic Differentiation of 3T3-L1 Cells
    Yosuke Masubuchi, Yuko Nakagawa, Jinhui Ma, Tsutomu Sasaki, Tadahiro Kitamura, Yoritsuna Yamamoto, Hitoshi Kurose, Itaru Kojima, Hiroshi Shibata, Xing-Ming Shi
    PLoS ONE.2013; 8(1): e54500.     CrossRef
  • Goût des aliments et comportement alimentaire
    M. Fantino
    Médecine des Maladies Métaboliques.2012; 6(5): 409.     CrossRef
  • The role of T1r3 and Trpm5 in carbohydrate-induced obesity in mice
    John I. Glendinning, Jennifer Gillman, Haley Zamer, Robert F. Margolskee, Anthony Sclafani
    Physiology & Behavior.2012; 107(1): 50.     CrossRef
  • Repair of diverse diabetic defects of β‐cells in man and mouse by pharmacological glucokinase activation
    Nicolai M. Doliba, Deborah Fenner, Bogumil Zelent, Joseph Bass, Ramakanth Sarabu, Franz M. Matschinsky
    Diabetes, Obesity and Metabolism.2012; 14(s3): 109.     CrossRef
Fuel-Stimulated Insulin Secretion Depends upon Mitochondria Activation and the Integration of Mitochondrial and Cytosolic Substrate Cycles
Gary W. Cline
Diabetes Metab J. 2011;35(5):458-465.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.458
  • 65,535 View
  • 38 Download
  • 9 Crossref
AbstractAbstract PDFPubReader   

The pancreatic islet β-cell is uniquely specialized to couple its metabolism and rates of insulin secretion with the levels of circulating nutrient fuels, with the mitochondrial playing a central regulatory role in this process. In the β-cell, mitochondrial activation generates an integrated signal reflecting rates of oxidativephosphorylation, Kreb's cycle flux, and anaplerosis that ultimately determines the rate of insulin exocytosis. Mitochondrial activation can be regulated by proton leak and mediated by UCP2, and by alkalinization to utilize the pH gradient to drive substrate and ion transport. Converging lines of evidence support the hypothesis that substrate cycles driven by rates of Kreb's cycle flux and by anaplerosis play an integral role in coupling responsive changes in mitochondrial metabolism with insulin secretion. The components and mechanisms that account for the integrated signal of ATP production, substrate cycling, the regulation of cellular redox state, and the production of other secondary signaling intermediates are operative in both rodent and human islet β-cells.

Citations

Citations to this article as recorded by  
  • Nicotinamide Adenine Dinucleotide: The Redox Sensor in Aging-Related Disorders
    Giovanna Schiuma, Djidjell Lara, James Clement, Marco Narducci, Roberta Rizzo
    Antioxidants & Redox Signaling.2024;[Epub]     CrossRef
  • ROCK1 regulates insulin secretion from β-cells
    Byung-Jun Sung, Sung-Bin Lim, Won-Mo Yang, Jae Hyeon Kim, Rohit N. Kulkarni, Young-Bum Kim, Moon-Kyu Lee
    Molecular Metabolism.2022; 66: 101625.     CrossRef
  • Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
    Xiaoting Luo, Jinzi Wu, Siqun Jing, Liang-Jun Yan
    Aging and disease.2016; 7(1): 90.     CrossRef
  • Characterization of Phospholipids in Insulin Secretory Granules and Mitochondria in Pancreatic Beta Cells and Their Changes with Glucose Stimulation
    Michael J. MacDonald, Lacmbouh Ade, James M. Ntambi, Israr-Ul H. Ansari, Scott W. Stoker
    Journal of Biological Chemistry.2015; 290(17): 11075.     CrossRef
  • Roles of Pyruvate, NADH, and Mitochondrial Complex I in Redox Balance and Imbalance inβCell Function and Dysfunction
    Xiaoting Luo, Rongrong Li, Liang-Jun Yan
    Journal of Diabetes Research.2015; 2015: 1.     CrossRef
  • Peroxisome Proliferator-activated Receptor γ (PPARγ) and Its Target Genes Are Downstream Effectors of FoxO1 Protein in Islet β-Cells
    Dhananjay Gupta, Averi A. Leahy, Navjot Monga, Mina Peshavaria, Thomas L. Jetton, Jack L. Leahy
    Journal of Biological Chemistry.2013; 288(35): 25440.     CrossRef
  • Desnutrin/ATGL Activates PPARδ to Promote Mitochondrial Function for Insulin Secretion in Islet β Cells
    Tianyi Tang, Marcia J. Abbott, Maryam Ahmadian, Andressa B. Lopes, Yuhui Wang, Hei Sook Sul
    Cell Metabolism.2013; 18(6): 883.     CrossRef
  • Potent humanin analog increases glucose‐stimulated insulin secretion through enhanced metabolism in the β cell
    Regina Kuliawat, Laura Klein, Zhenwei Gong, Marianna Nicoletta‐Gentile, Anjana Nemkal, Lingguang Cui, Claire Bastie, Kai Su, Derek Huffman, Manju Surana, Nir Barzilai, Norman Fleischer, Radhika Muzumdar
    The FASEB Journal.2013; 27(12): 4890.     CrossRef
  • Proliferation and differentiation of osteoblasts from the mandible of osteoporotic rats
    Shu-Juan Yu, Hong-Chen Liu, Ling-Ling E, Dong-Sheng Wang, Guo-Xiong Zhu
    Experimental Biology and Medicine.2012; 237(4): 395.     CrossRef
Editorial
The Association between Carotid Atherosclerosis and Glucose
Bo Kyung Koo
Diabetes Metab J. 2011;35(5):466-468.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.466
  • 65,535 View
  • 27 Download
PDFPubReader   
Original Articles
Protective Effect of Heme Oxygenase-1 on High Glucose-Induced Pancreatic β-Cell Injury
Eun-Mi Lee, Young-Eun Lee, Esder Lee, Gyeong Ryul Ryu, Seung-Hyun Ko, Sung-Dae Moon, Ki-Ho Song, Yu-Bae Ahn
Diabetes Metab J. 2011;35(5):469-479.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.469
  • 3,985 View
  • 37 Download
  • 19 Crossref
AbstractAbstract PDFPubReader   
Background

Glucose toxicity that is caused by chronic exposure to a high glucose concentration leads to islet dysfunction and induces apoptosis in pancreatic β-cells. Heme oxygenase-1 (HO-1) has been identified as an anti-apoptotic and cytoprotective gene. The purpose of this study is to investigate whether HO-1 up-regulation when using metalloprotophyrin (cobalt protoporphyrin, CoPP) could protect pancreatic β-cells from high glucose-induced apoptosis.

Methods

Reverse transcription-polymerase chain reaction was performed to analyze the CoPP-induced mRNA expression of HO-1. Cell viability of INS-1 cells cultured in the presence of CoPP was examined by acridine orange/propidium iodide staining. The generation of intracellular reactive oxygen species (ROS) was measured using flow cytometry. Glucose stimulated insulin secretion (GSIS) was determined following incubation with CoPP in different glucose concentrations.

Results

CoPP increased HO-1 mRNA expression in both a dose- and time-dependent manner. Overexpression of HO-1 inhibited caspase-3, and the number of dead cells in the presence of CoPP was significantly decreased when exposed to high glucose conditions (HG). CoPP also decreased the generation of intracellular ROS by 50% during 72 hours of culture with HG. However, decreased GSIS was not recovered even in the presence of CoPP.

Conclusion

Our data suggest that CoPP-induced HO-1 up-regulation results in protection from high glucose-induced apoptosis in INS-1 cells; however, glucose stimulated insulin secretion is not restored.

Citations

Citations to this article as recorded by  
  • Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
    Jeffrey Cummings, Andrew Ortiz, Janelle Castellino, Jefferson Kinney
    European Journal of Neuroscience.2022; 56(9): 5727.     CrossRef
  • The ischaemic preconditioning paradox and its implications for islet isolation from heart-beating and non heart-beating donors
    Daniel Brandhorst, Heide Brandhorst, Samuel Acreman, Paul R. V. Johnson
    Scientific Reports.2022;[Epub]     CrossRef
  • CYTOCHROMES OF MITOCHONDRIES AND ACTIVITY OF HEME METABOLISM ENZYMES IN THE LIVER UNDER DIFFERENT NUTRIENT REGIMES
    G.P. Kopylchuk, Z.-M. I. Grynenkiv, O.M. Voloshchuk
    Fiziolohichnyĭ zhurnal.2021; 67(2): 37.     CrossRef
  • Heme Oxygenase-1 (HMOX-1) and inhibitor of differentiation proteins (ID1, ID3) are key response mechanisms against iron-overload in pancreatic β-cells
    Mawieh Hamad, Abdul Khader Mohammed, Mahmood Y. Hachim, Debasmita Mukhopadhy, Anila Khalique, Amina Laham, Sarah Dhaiban, Khuloud Bajbouj, Jalal Taneera
    Molecular and Cellular Endocrinology.2021; 538: 111462.     CrossRef
  • Food-derived cyanidin-3-O-glucoside alleviates oxidative stress: evidence from the islet cell line and diabetic db/db mice
    Xiang Ye, Wen Chen, Pengcheng Tu, Ruoyi Jia, Yangyang Liu, Yonglu Li, Qiong Tang, Xiaodong Zheng, Qiang Chu
    Food & Function.2021; 12(22): 11599.     CrossRef
  • Telmisartan protects against high glucose/high lipid‐induced apoptosis and insulin secretion by reducing the oxidative and ER stress
    Yan Wang, Jingjing Xue, Yan Li, Xin Zhou, Shun Qiao, Dewu Han
    Cell Biochemistry and Function.2019; 37(3): 161.     CrossRef
  • Ropivacaine regulates the expression and function of heme oxygenase-1
    Xiangbiao Yan, Yu Li, Xuechang Han, Xu Dong, Yajie Zhang, Qunzhi Xing
    Biomedicine & Pharmacotherapy.2018; 103: 284.     CrossRef
  • A review on heme oxygenase-1 induction: is it a necessary evil
    Ajaz Ahmad Waza, Zeenat Hamid, Sajad Ali, Shabir Ahmad Bhat, Musadiq Ahmad Bhat
    Inflammation Research.2018; 67(7): 579.     CrossRef
  • Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects
    Hee Jae Lee, Hye In Seo, Hee Yun Cha, Yun Jung Yang, Soo Hyun Kwon, Soo Jin Yang
    Clinical Nutrition Research.2018; 7(4): 229.     CrossRef
  • Social, economic, and policy implications of organ preservation advances
    Alyssa Ward, David K. Klassen, Kate M. Franz, Sebastian Giwa, Jedediah K. Lewis
    Current Opinion in Organ Transplantation.2018; 23(3): 336.     CrossRef
  • Geniposide protects pancreatic β cells from high glucose‐mediated injury by activation of AMP‐activated protein kinase
    Chunyan Liu, Yanan Hao, Fei Yin, Yonglan Zhang, Jianhui Liu
    Cell Biology International.2017; 41(5): 544.     CrossRef
  • Eff ects of hemin, a heme oxygenase-1 inducer in L-arginine-induced acute pancreatitis and associated lung injury in adult male albino rats
    N. M. Aziz, M. Y. Kamel, R. A. Rifaai
    Endocrine Regulations.2017; 51(1): 20.     CrossRef
  • Downregulation of microRNA-155 ameliorates high glucose-induced endothelial injury by inhibiting NF-κB activation and promoting HO-1 and NO production
    Xi Zhang, Xiangyang Liu, Yang Li, Jingbo Lai, Nana Zhang, Jie Ming, Xianjie Ma, Qiuhe Ji, Ying Xing
    Biomedicine & Pharmacotherapy.2017; 88: 1227.     CrossRef
  • Sulforaphane Protects against High Cholesterol-Induced Mitochondrial Bioenergetics Impairments, Inflammation, and Oxidative Stress and Preserves Pancreaticβ-Cells Function
    Catalina Carrasco-Pozo, Kah Ni Tan, Martin Gotteland, Karin Borges
    Oxidative Medicine and Cellular Longevity.2017; 2017: 1.     CrossRef
  • Aromatic malononitriles stimulate the resistance of insulin-producing beta-cells to oxidants and inflammatory cytokines
    Kyril Turpaev, Nils Welsh
    European Journal of Pharmacology.2016; 784: 69.     CrossRef
  • Differences in insulin biosynthesis pathway between small and large islets do not correspond to insulin secretion
    Han-Hung Huang, Lisa Stehno-Bittel
    Islets.2015; 7(5): e1129097.     CrossRef
  • A newly identified polysaccharide from Ganoderma atrum attenuates hyperglycemia and hyperlipidemia
    Kexue Zhu, Shaoping Nie, Chuan Li, Suli Lin, Mengmeng Xing, Wenjuan Li, Deming Gong, Mingyong Xie
    International Journal of Biological Macromolecules.2013; 57: 142.     CrossRef
  • Glycated Albumin Causes Pancreatic β-Cells Dysfunction Through Autophagy Dysfunction
    Young Mi Song, Sun Ok Song, Young-Hye You, Kun-Ho Yoon, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Ji-Won Kim, Byung-Wan Lee
    Endocrinology.2013; 154(8): 2626.     CrossRef
  • Chronic Resveratrol Treatment Protects Pancreatic Islets against Oxidative Stress in db/db Mice
    Young-Eun Lee, Ji-Won Kim, Eun-Mi Lee, Yu-Bae Ahn, Ki-Ho Song, Kun-Ho Yoon, Hyung-Wook Kim, Cheol-Whee Park, Guolian Li, Zhenqi Liu, Seung-Hyun Ko, Kathrin Maedler
    PLoS ONE.2012; 7(11): e50412.     CrossRef
The Effects of Glyburide on Apoptosis and Endoplasmic Reticulum Stress in INS-1 Cells in a Glucolipotoxic Condition
Min Jeong Kwon, Hye Suk Chung, Chang Shin Yoon, Jung Hae Ko, Hae Jung Jun, Tae Kyun Kim, Soon Hee Lee, Kyung Soo Ko, Byoung Doo Rhee, Mi Kyung Kim, Jeong Hyun Park
Diabetes Metab J. 2011;35(5):480-488.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.480
  • 4,034 View
  • 43 Download
  • 6 Crossref
AbstractAbstract PDFPubReader   
Background

β-cell death due to endoplasmic reticulum (ER) stress has been regarded as an important pathogenic component of type 2 diabetes. The possibility has been suggested that sulfonylurea, currently being used as one of the main oral hypoglycemic agents of type 2 diabetes, increases ER stress, which could lead to sulfonylurea failure. The authors of the present study examined ER stress of β-cells in a glucolipotoxic condition using glyburide (GB) in an environment mimicking type 2 diabetes.

Methods

Apoptosis was induced by adding various concentrations of GB (0.001 to 200 µM) to a glucolipotoxic condition using 33 mM glucose, and the effects of varied concentrations of palmitate were evaluated via annexin V staining. The markers of ER stress and pro-apoptotic markers were assessed by Western blotting and semi-quantitative reverse transcription-polymerase chain reaction. Additionally, the anti-apoptotic markers were evaluated.

Results

Addition of any concentration of GB in 150 µM palmitate and 33 mM glucose did not increase apoptosis. The expression of phosphorylated eukaryotic initiation factor (eIF-2α) was increased and cleaved caspase 3 was decreased by adding GB to a glucolipotoxic condition. However, other ER stress-associated markers such as Bip-1, X-box binding protein-1, ATF-4 and C/EBP-homologous protein transcription factor and anti-apoptotic markers phosphor-p85 phosphatidylinositol 3-kinase and phosphorylation of Akt did not change significantly.

Conclusion

GB did not show further deleterious effects on the degree of apoptosis or ER stress of INS-1 cells in a glucolipotoxic condition. Increased phosphorylation of eIF-2α may attenuate ER stress for adaptation to increased ER protein load.

Citations

Citations to this article as recorded by  
  • The antagonistic atorvastatin-glibenclamide interactions suppressed the atorvastatin-induced Bax/cytochrome c/p53 mRNA expressions and increased Rho A mRNA expression in B16f10 melanoma cell culture
    Maryam Malek, Nasim Dana, Ahmad Ghasemi, Maedeh Ghasemi
    Gene Reports.2021; 23: 101156.     CrossRef
  • Expression profiles of stress-related genes in islets from donors with progressively impaired glucose metabolism
    Marcus Lundberg, Anton Stenwall, Angie Tegehall, Olle Korsgren, Oskar Skog
    Islets.2018; 10(2): 69.     CrossRef
  • Pharmacological Modulators of Endoplasmic Reticulum Stress in Metabolic Diseases
    Tae Jung, Kyung Choi
    International Journal of Molecular Sciences.2016; 17(2): 192.     CrossRef
  • The TRPA1 channel and oral hypoglycemic agents
    Carlos Manlio Diaz-Garcia
    Channels.2013; 7(6): 420.     CrossRef
  • Dimethyl sulfoxide reduces hepatocellular lipid accumulation through autophagy induction
    Young Mi Song, Sun-Ok Song, Yong-Keun Jung, Eun-Seok Kang, Bong Soo Cha, Hyun Chul Lee, Byung-Wan Lee
    Autophagy.2012; 8(7): 1085.     CrossRef
  • The Duration of Sulfonylurea Treatment Is Associated withβ-Cell Dysfunction in Patients with Type 2 Diabetes Mellitus
    Mi-Seon Shin, Jee Hee Yu, Chang Hee Jung, Jenie Yoonoo Hwang, Woo Je Lee, Min-Seon Kim, Joong-Yeol Park
    Diabetes Technology & Therapeutics.2012; 14(11): 1033.     CrossRef
Dietary Oleate Has Beneficial Effects on Every Step of Non-Alcoholic Fatty Liver Disease Progression in a Methionine- and Choline-Deficient Diet-Fed Animal Model
Ji Young Lee, Jae Hoon Moon, Jong Suk Park, Byung-Wan Lee, Eun Seok Kang, Chul Woo Ahn, Hyun Chul Lee, Bong Soo Cha
Diabetes Metab J. 2011;35(5):489-496.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.489
  • 30,503 View
  • 36 Download
  • 17 Crossref
AbstractAbstract PDFPubReader   
Background

Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a major cause of liver-related morbidity and mortality. The underlying mechanisms of disease progression remain poorly understood, and primary therapy of NAFLD is not yet established. We investigated the effects of dietary oleate on the development and progression of NAFLD in a methionine- and choline-deficient (MCD) diet-fed animal model.

Methods

A total of 30 C57BL/6J mice were randomly divided into three groups (n=10 in each group) and fed various experimental diets for four weeks: chow, MCD diet, or OMCD (MCD diet with oleate, 0.5 mg/g/day). Liver samples were examined for steatohepatitis and fibrosis parameters and associated genes.

Results

Additional dietary oleate dramatically reduced MCD diet-induced hepatic steatosis. Hepatic carbohydrate responsive element-binding protein was overexpressed in MCD diet-fed mice, and dietary oleate prevented this overexpression (P<0.001). Dietary oleate partially prevented MCD diet-induced serum level increases in aspartate aminotransferase and alanine aminotransferase (P<0.001, respectively). The mRNA expressions of hepatic monocyte chemoattractant protein 1, tumor necrosis factor-α and matrix metalloproteinase-9 were increased in MCD diet-fed mice, and this overexpression of inflammatory molecules was prevented by dietary oleate (P<0.001). Hepatic pericellular fibrosis was observed in MCD diet-fed mice, and dietary oleate prevented this fibrosis. Altogether, dietary oleate prevented MCD diet-induced hepatic steatosis, inflammation and fibrosis.

Conclusion

Dietary oleate has beneficial effects in every step of NAFLD development and progression and could be a nutritional option for NAFLD prevention and treatment.

Citations

Citations to this article as recorded by  
  • Bidirectional association between NAFLD and gallstone disease: a systematic review and meta-analysis of observational studies
    Shengying Gu, Shanshan Hu, Shuowen Wang, Chendong Qi, Chenyang Shi, Guorong Fan
    Expert Review of Gastroenterology & Hepatology.2023; 17(3): 283.     CrossRef
  • The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease
    Camelia Munteanu, Betty Schwartz
    Antioxidants.2023; 12(4): 903.     CrossRef
  • Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
    Anja Hess, Stefan D Gentile, Amel Ben Saad, Raza‐Ur Rahman, Tim Habboub, Daniel S Pratt, Alan C Mullen
    The EMBO Journal.2023;[Epub]     CrossRef
  • Histopathological Examination of the Effects of Tocilizumab and Dexamethasone on the Liver in Rats of Oleic Acid induced Acute Lung Injury
    Funda TERZİ, Hüseyin Serkan EROL
    Balıkesır Health Sciences Journal.2022;[Epub]     CrossRef
  • Identifying Lipid Metabolites Influenced by Oleic Acid Administration Using High-Performance Liquid Chromatography–Mass Spectrometry-Based Lipidomics
    Chao Xu, Dan Song, Askild L. Holck, Youyou Zhou, Rong Liu
    ACS Omega.2020; 5(20): 11314.     CrossRef
  • Causative and Sanative dynamicity of ChREBP in Hepato-Metabolic disorders
    P. Vineeth Daniel, Prosenjit Mondal
    European Journal of Cell Biology.2020; 99(8): 151128.     CrossRef
  • PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation
    Lei Tong, Long Wang, Shuangshuang Yao, Lina Jin, Jian Yang, Yifei Zhang, Guang Ning, Zhiguo Zhang
    Cell Death & Disease.2019;[Epub]     CrossRef
  • Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels
    Jianzhong Ye, Longxian Lv, Wenrui Wu, Yating Li, Ding Shi, Daiqiong Fang, Feifei Guo, Huiyong Jiang, Ren Yan, Wanchun Ye, Lanjuan Li
    Frontiers in Microbiology.2018;[Epub]     CrossRef
  • Olive oil combined with Lycium barbarum polysaccharides attenuates liver apoptosis and inflammation induced by carbon tetrachloride in rats
    Yun-Yun Chiang, Jane C.-J. Chao
    Journal of Functional Foods.2018; 48: 329.     CrossRef
  • Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling
    Simon Ducheix, Alexandra Montagner, Arnaud Polizzi, Frédéric Lasserre, Marion Régnier, Alice Marmugi, Fadila Benhamed, Justine Bertrand-Michel, Laila Mselli-Lakhal, Nicolas Loiseau, Pascal G. Martin, Jean-Marc Lobaccaro, Laurent Ferrier, Catherine Postic,
    PLOS ONE.2017; 12(7): e0181393.     CrossRef
  • Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β
    Simon Ducheix, Maria Carmela Vegliante, Gaetano Villani, Nicola Napoli, Carlo Sabbà, Antonio Moschetta
    Cellular and Molecular Life Sciences.2016; 73(20): 3809.     CrossRef
  • Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway
    Young Mi Song, Yong-ho Lee, Ji-Won Kim, Dong-Sik Ham, Eun-Seok Kang, Bong Soo Cha, Hyun Chul Lee, Byung-Wan Lee
    Autophagy.2015; 11(1): 46.     CrossRef
  • Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease
    Sanja Stojsavljević
    World Journal of Gastroenterology.2014; 20(48): 18070.     CrossRef
  • Microglial Cell Activation Increases Saturated and Decreases Monounsaturated Fatty Acid Content, but Both Lipid Species are Proinflammatory
    Emily B. Button, Andrew S. Mitchell, Marcia M. Domingos, Jessica H.‐J. Chung, Ryan M. Bradley, Ashkan Hashemi, Phillip M. Marvyn, Ashley C. Patterson, Ken D. Stark, Joe Quadrilatero, Robin E. Duncan
    Lipids.2014; 49(4): 305.     CrossRef
  • Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse
    Jesse D. Riordan, Joseph H. Nadeau
    Mammalian Genome.2014; 25(9-10): 473.     CrossRef
  • Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH
    Stephan Laggai, Yvette Simon, Theo Ranssweiler, Alexandra K Kiemer, Sonja M Kessler
    World Journal of Hepatology.2013; 5(10): 558.     CrossRef
  • Dimethyl sulfoxide reduces hepatocellular lipid accumulation through autophagy induction
    Young Mi Song, Sun-Ok Song, Yong-Keun Jung, Eun-Seok Kang, Bong Soo Cha, Hyun Chul Lee, Byung-Wan Lee
    Autophagy.2012; 8(7): 1085.     CrossRef
Carotid Intimal-Medial Thickness Is Not Increased in Women with Previous Gestational Diabetes Mellitus
Yun Hyi Ku, Sung Hee Choi, Soo Lim, Young Min Cho, Young Joo Park, Kyong Soo Park, Seong Yeon Kim, Hak Chul Jang
Diabetes Metab J. 2011;35(5):497-503.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.497
  • 3,736 View
  • 40 Download
  • 10 Crossref
AbstractAbstract PDFPubReader   
Background

Gestational diabetes mellitus (GDM) is known to increase the risk of cardiovascular diseases. Measuring the carotid artery intimal-medial thickness (CIMT) is a non-invasive technique used to evaluate early atherosclerosis and to predict future cardiovascular diseases. We examined the association between CIMT and cardiovascular risk factors in young Korean women with previous GDM.

Methods

One hundred one women with previous GDM and 19 women who had normal pregnancies (NP) were recruited between 1999 and 2002. At one year postpartum, CIMT was measured using high-resolution B-mode ultrasonography, and oral glucose tolerance tests were performed. Fasting glucose, glycated hemoglobin A1c (HbA1c), insulin levels and lipid profiles were also measured. CIMTs in the GDM and NP groups were compared, and the associations between CIMT and cardiovascular risk factors were analyzed in the GDM group.

Results

CIMT results of the GDM group were not significantly different from those of the NP group (GDM, 0.435±0.054 mm; NP, 0.460±0.046 mm; P=0.069). In the GDM group, a higher HbA1c was associated with an increase in CIMT after age adjustment (P=0.011). CIMT results in the group with HbA1c >6.0% were higher than those of the normal HbA1c (HbA1c ≤6.0%) (P=0.010). Nine of the patients who are type 2 diabetes mellitus converters within one year postpartum but showed no significant difference in CIMT results compared to NP group.

Conclusion

Higher HbA1c is associated with an increase in CIMT in women with previous GDM. However, CIMT at one year postpartum was not increased in these women compared to that in NP women.

Citations

Citations to this article as recorded by  
  • Women with a history of gestational diabetes mellitus present an accumulation of cardiovascular risk factors at age 46—A birth cohort study
    Evi Bakiris, Kaisu Luiro, Jari Jokelainen, Laure Morin‐Papunen, Sirkka Keinänen‐Kiukaanniemi, Kari Kaikkonen, Terhi Piltonen, Juha S. Tapanainen, Juha Auvinen
    Acta Obstetricia et Gynecologica Scandinavica.2024; 103(7): 1318.     CrossRef
  • The effect of gestational diabetes mellitus on carotid artery intima-media thickness in and after pregnancy: a systematic review and meta-analysis
    Andrea Sonaglioni, Elisabetta Piergallini, Angelo Naselli, Gian Luigi Nicolosi, Anna Ferrulli, Stefano Bianchi, Michele Lombardo, Giuseppe Ambrosio
    Acta Diabetologica.2023;[Epub]     CrossRef
  • Prognostic indicators of persistent carotid intima-media thickness increase in postpartum period in a population of normotensive women with gestational diabetes mellitus
    Andrea Sonaglioni, Gian Luigi Nicolosi, Valentina Esposito, Stefano Bianchi, Michele Lombardo
    European Journal of Obstetrics & Gynecology and Reproductive Biology.2022; 269: 47.     CrossRef
  • Pharmacotherapy for gestational diabetes
    Angelo Maria Patti, Rosaria Vincenza Giglio, Kalliopi Pafili, Manfredi Rizzo, Nikolaos Papanas
    Expert Opinion on Pharmacotherapy.2018; 19(13): 1407.     CrossRef
  • Women with a history of gestational diabetes on long-term follow up have normal vascular function despite more dysglycemia, dyslipidemia and adiposity
    Olubukola Ajala, Louise A. Jensen, Edmond Ryan, Constance Chik
    Diabetes Research and Clinical Practice.2015; 110(3): 309.     CrossRef
  • Gestational Diabetes Mellitus in Korean Women: Similarities and Differences from Other Racial/Ethnic Groups
    Catherine Kim
    Diabetes & Metabolism Journal.2014; 38(1): 1.     CrossRef
  • History of Gestational Diabetes Mellitus and Future Risk of Atherosclerosis in Mid‐life: The Coronary Artery Risk Development in Young Adults Study
    Erica P. Gunderson, Vicky Chiang, Mark J. Pletcher, David R. Jacobs, Charles P. Quesenberry, Stephen Sidney, Cora E. Lewis
    Journal of the American Heart Association.2014;[Epub]     CrossRef
  • Association of Gestational Diabetes Mellitus (GDM) with subclinical atherosclerosis: a systemic review and meta-analysis
    Jing-Wei Li, Si-Yi He, Peng Liu, Lin Luo, Liang Zhao, Ying-Bin Xiao
    BMC Cardiovascular Disorders.2014;[Epub]     CrossRef
  • Cardiovascular Disease Risk in the Offspring of Diabetic Women: The Impact of the Intrauterine Environment
    Laura J. Marco, Kate McCloskey, Peter J. Vuillermin, David Burgner, Joanne Said, Anne-Louise Ponsonby
    Experimental Diabetes Research.2012; 2012: 1.     CrossRef
  • The Association between Carotid Atherosclerosis and Glucose
    Bo Kyung Koo
    Diabetes & Metabolism Journal.2011; 35(5): 466.     CrossRef
Prevalence of Chronic Complications in Korean Patients with Type 2 Diabetes Mellitus Based on the Korean National Diabetes Program
Sang Youl Rhee, Suk Chon, Mi Kwang Kwon, Ie Byung Park, Kyu Jeung Ahn, In Ju Kim, Sung-Hoon Kim, Hyoung Woo Lee, Kyung Soo Koh, Doo Man Kim, Sei Hyun Baik, Kwan Woo Lee, Moon Suk Nam, Yong Soo Park, Jeong-taek Woo, Young Seol Kim
Diabetes Metab J. 2011;35(5):504-512.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.504
  • 4,772 View
  • 40 Download
  • 52 Crossref
AbstractAbstract PDFPubReader   
Background

The Korean National Diabetes Program (KNDP) cohort study is performing an ongoing large-scale prospective multicenter investigation to discover the pathogenesis of type 2 diabetes in Korean patients. This study was performed to examine the prevalence of chronic complications in patients with type 2 diabetes among those registered in the KNDP cohort within the past 4 years.

Methods

This study was performed between June 2006 and September 2009 at 13 university hospitals and included 4,265 KNDP cohort participants. Among the participants, the crude prevalence of microvascular and macrovascular diseases of those checked for diabetes-related complications was determined, and the adjusted standard prevalence and standardization of the general population prevalence ratio (SPR) was estimated based on the 2005 Korean National Health and Nutrition Examination Survey (KNHANES) population demographics.

Results

Among the KNDP registrants, 43.2% had hypertension, 34.8% had dyslipidemia, 10.8% had macrovascular disease, and 16.7% had microvascular disease. The SPR of the KNDP registrants was significantly higher than that of the KNHANES subjects after adjusting for demographics in the KNHANES 2005 population. However, with the exception of cardiovascular disease in females, the standardized prevalence for the most complicated items in the survey was significantly higher than that in the KNHANES subjects.

Conclusion

The prevalence of macrovascular disease and peripheral vascular disease were significantly higher in Korean patients with type 2 diabetes than in the normal population. However, no significant difference was noted in the prevalence of cardiovascular disease in females.

Citations

Citations to this article as recorded by  
  • Impact of diabetes distress on glycemic control and diabetic complications in type 2 diabetes mellitus
    Hye-Sun Park, Yongin Cho, Da Hea Seo, Seong Hee Ahn, Seongbin Hong, Young Ju Suh, Suk Chon, Jeong-Taek Woo, Sei Hyun Baik, Kwan Woo Lee, So Hun Kim
    Scientific Reports.2024;[Epub]     CrossRef
  • Clinical and economic impact of changing reimbursement criteria for statin treatment among patients with type 2 diabetes mellitus in South Korea
    Siin Kim, Kyungseon Choi, Ji-yool Kim, Hae Sun Suh
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • The Promising First Cohort Study in Korean Patients with Obesity and Overweight: Gangwon Obesity and Metabolic Syndrome Study
    Eun-Jung Rhee
    Journal of Obesity & Metabolic Syndrome.2022; 31(4): 285.     CrossRef
  • Impact of noncommunicable disease conditions and physical burden on intent to leave midwifery in Hungary
    Krisztina Éles Gebriné, Kinga Lampek, Péter Takács, Miklós Zrínyi, Attila Sárváry, Andrea Sárváry
    Kontakt.2021; 23(1): 45.     CrossRef
  • Dietary glutamic acid and aspartic acid as biomarkers for predicting diabetic retinopathy
    So Young Park, Jieun Kim, Jung Il Son, Sang Youl Rhee, Do-Yeon Kim, Suk Chon, Hyunjung Lim, Jeong-Taek Woo
    Scientific Reports.2021;[Epub]     CrossRef
  • Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
    Ja Young Jeon
    Diabetes & Metabolism Journal.2021; 45(4): 613.     CrossRef
  • Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
    Kyoung Jin Kim, Jimi Choi, Jae Hyun Bae, Kyeong Jin Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim, Nam Hoon Kim
    Diabetes & Metabolism Journal.2021; 45(4): 617.     CrossRef
  • Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
    Sang Ouk Chin, In Gyoon Ha, Sang Youl Rhee, Su Jin Jeong, Suk Chon, Sung Hoon Kim, Kyu Jeung Ahn, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Jeong Taek Woo
    International Journal of Endocrinology.2020; 2020: 1.     CrossRef
  • Perioperative anesthetic management of patients with diabetes mellitus: focused on blood glucose control
    Hyungseok Seo
    Journal of the Korean Medical Association.2020; 63(9): 526.     CrossRef
  • Predicting Old-age Mortality Using Principal Component Analysis: Results from a National Panel Survey in Korea
    Jaeyong Shin, Kwang-Soo Lee, Jae-Hyun Kim
    Medicina.2020; 56(7): 360.     CrossRef
  • A relationship between endoscopic findings and diabetic regulation, and complications in patients with diabetes mellitus
    Sevki Konur
    Archives of Medical Science – Civilization Diseases.2020; 5(1): 53.     CrossRef
  • Randomized control trial comparing the effect of cilostazol and aspirin on changes in carotid intima-medial thickness
    Sangmo Hong, Munsuk Nam, Bertis B. Little, Seihyun Paik, Kwanwoo Lee, Jungtaek Woo, Dooman Kim, Jungoo Kang, Minyoung Chun, Yongsoo Park
    Heart and Vessels.2019; 34(11): 1758.     CrossRef
  • Genome‐wide association study identifies new susceptibility loci for diabetic nephropathy in Korean patients with type 2 diabetes mellitus
    Kyung H. Jeong, Jin S. Kim, Jeong‐Taek Woo, Sang Y. Rhee, Yu H. Lee, Yang G. Kim, Ju‐Young Moon, Su K. Kim, Sun W. Kang, Sang H. Lee, Yeong H. Kim
    Clinical Genetics.2019; 96(1): 35.     CrossRef
  • Presence of Carotid Plaque Is Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Normal Renal Function
    Da Hea Seo, So Hun Kim, Joon Ho Song, Seongbin Hong, Young Ju Suh, Seong Hee Ahn, Jeong-Taek Woo, Sei Hyun Baik, Yongsoo Park, Kwan Woo Lee, Young Seol Kim, Moonsuk Nam
    Diabetes & Metabolism Journal.2019; 43(6): 840.     CrossRef
  • The relationship between demographic and anthropometric characteristics and diabetic complications and number of hospitalizations in hospitalized diabetic patients
    Yusuf Kayar, Mehmet Agin
    Archives of Medical Science – Civilization Diseases.2019; 4(1): 7.     CrossRef
  • Importance of family history of diabetes in computing a diabetes risk score in Korean prediabetic population
    Morena Ustulin, Sang Youl Rhee, Suk Chon, Kyu Keung Ahn, Ji Eun Lim, Bermseok Oh, Sung-Hoon Kim, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Young Seol Kim, Jeong-Taek Woo
    Scientific Reports.2018;[Epub]     CrossRef
  • Characteristics of frequent emergency department users with type 2 diabetes mellitus in Korea
    Morena Ustulin, Junghoon Woo, Jeong‐taek Woo, Sang Youl Rhee
    Journal of Diabetes Investigation.2018; 9(2): 430.     CrossRef
  • Implementation of the Chronic Disease Care System and its association with health care costs and continuity of care in Korean adults with type 2 diabetes mellitus
    Woorim Kim, Yoon Soo Choy, Sang Ah Lee, Eun-Cheol Park
    BMC Health Services Research.2018;[Epub]     CrossRef
  • Long‐term effects on glycaemic control and β‐cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial
    Suk Chon, Sang Youl Rhee, Kyu Jeung Ahn, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Soon Jib Yoo, Gwanpyo Koh, Dae Ho Lee, Young Seol Kim, Jeong‐Taek Woo
    Diabetes, Obesity and Metabolism.2018; 20(5): 1121.     CrossRef
  • Cardio-Ankle Vascular Index as a Surrogate Marker of Early Atherosclerotic Cardiovascular Disease in Koreans with Type 2 Diabetes Mellitus
    So Young Park, Sang Ook Chin, Sang Youl Rhee, Seungjoon Oh, Jeong-Taek Woo, Sung Woon Kim, Suk Chon
    Diabetes & Metabolism Journal.2018; 42(4): 285.     CrossRef
  • Metformin reduces the risk of cancer in patients with type 2 diabetes
    Hae Jin Kim, SooJin Lee, Ki Hong Chun, Ja Young Jeon, Seung Jin Han, Dae Jung Kim, Young Seol Kim, Jeong-Taek Woo, Moon-Suk Nam, Sei Hyun Baik, Kyu Jeung Ahn, Kwan Woo Lee
    Medicine.2018; 97(8): e0036.     CrossRef
  • Impact of Socioeconomic Status on Health Behaviors, Metabolic Control, and Chronic Complications in Type 2 Diabetes Mellitus
    So Hun Kim, Seung Youn Lee, Chei Won Kim, Young Ju Suh, Seongbin Hong, Seong Hee Ahn, Da Hae Seo, Moon-Suk Nam, Suk Chon, Jeong-Taek Woo, Sei Hyun Baik, Yongsoo Park, Kwan Woo Lee, Young Seol Kim
    Diabetes & Metabolism Journal.2018; 42(5): 380.     CrossRef
  • Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program
    Ja Young Jeon, Soo Jin Lee, Sieun Lee, Soo Jin Kim, Seung Jin Han, Hae Jin Kim, Dae Jung Kim, Young Seol Kim, Jeong Taek Woo, Kyu Jeung Ahn, Moonsuk Nam, Sei Hyun Baik, Yongsoo Park, Kwan‐Woo Lee
    Journal of Diabetes Investigation.2018; 9(5): 1144.     CrossRef
  • Prediction of Coronary Heart Disease Risk in Korean Patients with Diabetes Mellitus
    Bo Kyung Koo, Sohee Oh, Yoon Ji Kim, Min Kyong Moon
    Journal of Lipid and Atherosclerosis.2018; 7(2): 110.     CrossRef
  • Diagnosis and Management of Diabetic Foot
    Chang Won Lee
    The Journal of Korean Diabetes.2018; 19(3): 168.     CrossRef
  • Clinical characteristics and risk factors for retinal diabetic neurodegeneration in type 2 diabetes
    Kiyoung Kim, Eung Suk Kim, Sang Youl Rhee, Suk Chon, Jeong-taek Woo, Seung-Young Yu
    Acta Diabetologica.2017; 54(11): 993.     CrossRef
  • Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data
    Sejeong Park, Sang Youl Rhee, Su Jin Jeong, Kiyoung Kim, Suk Chon, Seung-Young Yu, Jeong-Taek Woo
    Diabetes & Metabolism Journal.2017; 41(5): 393.     CrossRef
  • Clinical heterogeneity of type 1 diabetes (T1D) found in Asia
    Yongsoo Park, Kupper A. Wintergerst, Zhiguang Zhou
    Diabetes/Metabolism Research and Reviews.2017;[Epub]     CrossRef
  • Response: Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data (Diabetes Metab J 2017;41:393-404)
    Sang Youl Rhee, Jeong-Taek Woo
    Diabetes & Metabolism Journal.2017; 41(6): 494.     CrossRef
  • Current status of managing diabetes mellitus in Korea
    Kyoung Hwa Ha, Dae Jung Kim
    The Korean Journal of Internal Medicine.2016; 31(5): 845.     CrossRef
  • Hypoglycemia is associated with dementia in elderly patients with type 2 diabetes mellitus: An analysis based on the Korea National Diabetes Program Cohort
    Sang Ouk Chin, Sang Youl Rhee, Suk Chon, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Ki Hong Chun, Jeong-taek Woo, Young Seol Kim
    Diabetes Research and Clinical Practice.2016; 122: 54.     CrossRef
  • Relationship between fruit and fish intakes and cardiovascular disease risk factors in Korean women with type 2 diabetes mellitus: Based on the 4th and 5th Korea National Health and Nutrition Examination Surveys
    Ji Soo Oh, Hyesook Kim, Ki Nam Kim, Namsoo Chang
    Journal of Nutrition and Health.2016; 49(5): 304.     CrossRef
  • Hypoglycemia and Medical Expenses in Patients with Type 2 Diabetes Mellitus: An Analysis Based on the Korea National Diabetes Program Cohort
    Sang Youl Rhee, Soo Min Hong, Suk Chon, Kyu Jeung Ahn, Sung Hoon Kim, Sei Hyun Baik, Yong Soo Park, Moon Suk Nam, Kwan Woo Lee, Jeong-Taek Woo, Young Seol Kim, Zhengdong Zhang
    PLOS ONE.2016; 11(2): e0148630.     CrossRef
  • Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study
    Tae-Seok Lim, Jae-Seung Yun, Seon-Ah Cha, Ki-Ho Song, Ki-Dong Yoo, Yu-Bae Ahn, Yong-Moon Park, Seung-Hyun Ko
    The Korean Journal of Internal Medicine.2016; 31(6): 1110.     CrossRef
  • Low Economic Status Is Identified as an Emerging Risk Factor for Diabetes Mellitus in Korean Men Aged 30 to 59 Years in Korean National Health and Nutrition Examination Survey 2008 to 2010
    Bo Kyung Koo, Sang Wan Kim, Ka Hee Yi, Min Kyong Moon
    Diabetes & Metabolism Journal.2015; 39(2): 137.     CrossRef
  • Assessment of glycemic control in patients with type 2 diabetes mellitus treated with metformin–sulfonylurea combination: Results of a multicenter, cross‐sectional, observational study in Korea
    Sin Gon Kim, Jong Ryeal Hahm, Duk Kyu Kim, Sung Rae Cho, Dong Seop Choi
    Journal of Diabetes Investigation.2015; 6(3): 317.     CrossRef
  • Clinical and Economic Outcomes in Medication-Adherent and -Nonadherent Patients With Type 2 Diabetes Mellitus in the Republic of Korea
    So-Yeon An, Hae Jin Kim, Ki Hong Chun, Tae Ho Kim, Ja Young Jeon, Dae Jung Kim, Seung Jin Han, Young Seol Kim, Jeong Taek Woo, Kyu Jeung Ahn, Yongsoo Park, Moonsuk Nam, Sei Hyun Baik, Kwan-Woo Lee
    Clinical Therapeutics.2014; 36(2): 245.     CrossRef
  • Serum Magnesium Level Is Associated with Type 2 Diabetes in Women with a History of Gestational Diabetes Mellitus: The Korea National Diabetes Program Study
    Sae Jeong Yang, Soon Young Hwang, Sei Hyun Baik, Kwan Woo Lee, Moon Suk Nam, Yong Soo Park, Jeong Taek Woo, Young Seol Kim, Sunmin Park, So-Young Park, Chang Hoon Yim, Hyun Koo Yoon, Sung-Hoon Kim
    Journal of Korean Medical Science.2014; 29(1): 84.     CrossRef
  • Heart rate variability in children with type 1 diabetes mellitus
    Camila Balsamo Gardim, Bruno Affonso P. de Oliveira, Aline Fernanda B. Bernardo, Rayana Loch Gomes, Francis Lopes Pacagnelli, Roselene Modolo R. Lorençoni, Luiz Carlos M. Vanderlei
    Revista Paulista de Pediatria.2014; 32(2): 279.     CrossRef
  • Development of an HbA1c-Based Conversion Equation for Estimating Glycated Albumin in a Korean Population with a Wide Range of Glucose Intolerance
    Chang Hee Jung, You-Cheol Hwang, Kwang Joon Kim, Bong Soo Cha, Cheol-Young Park, Won Seon Jeon, Jae Hyeon Kim, Sang-Man Jin, Sang Youl Rhee, Jeong-taek Woo, Byung-Wan Lee, Sompop Bencharit
    PLoS ONE.2014; 9(4): e95729.     CrossRef
  • It's Still Not Too Late to Make a Change: Current Status of Glycemic Control in Korea
    Sang Yong Kim
    Diabetes & Metabolism Journal.2014; 38(3): 194.     CrossRef
  • Prevalence and factors associated with diabetic retinopathy in a Korean adult population: The 2008–2009 Korea National Health and Nutrition Examination Survey
    Ju Yean Yang, Na Kyung Kim, Yun Jeong Lee, Jung Hyun Noh, Dae Jung Kim, Kyung Soo Ko, Byoung Doo Rhee, Dong-Jun Kim
    Diabetes Research and Clinical Practice.2013; 102(3): 218.     CrossRef
  • Increasing achievement of the target goals for glycemic, blood pressure and lipid control for adults with diagnosed diabetes in Korea
    Sung Hoon Yu, Jun Goo Kang, Yoo‐Cheol Hwang, Kyu Jeung Ahn, Hyung Joon Yoo, Hong Yup Ahn, Sung Woo Park, Cheol‐Young Park
    Journal of Diabetes Investigation.2013; 4(5): 460.     CrossRef
  • Hemoglobin A1c May Be an Inadequate Diagnostic Tool for Diabetes Mellitus in Anemic Subjects
    Jung Il Son, Sang Youl Rhee, Jeong-taek Woo, Jin Kyung Hwang, Sang Ouk Chin, Suk Chon, Seungjoon Oh, Sung Woon Kim, Young Seol Kim
    Diabetes & Metabolism Journal.2013; 37(5): 343.     CrossRef
  • Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus
    Hye Jin Yoo, Soon Young Hwang, Ho Cheol Hong, Hae Yoon Choi, Sae Jeong Yang, Kwan Woo Lee, Moon Suk Nam, Yong Soo Park, Jeong Taek Woo, Young Seol Kim, Kyung Mook Choi, Sei Hyun Baik
    Endocrine.2013; 44(3): 680.     CrossRef
  • Comparison of Two Creatinine-Based Equations for Predicting Decline in Renal Function in Type 2 Diabetic Patients with Nephropathy in a Korean Population
    Eun Young Lee, Young-Mi Lee, Kyu Hun Choi, Hyun Chul Lee, Byung-Wan Lee, Beom Seok Kim
    International Journal of Endocrinology.2013; 2013: 1.     CrossRef
  • Association between Nutrient Intake and Obesity in Type 2 Diabetic Patients from the Korean National Diabetes Program: A Cross-Sectional Study
    So Hun Kim, Seong Bin Hong, Young Ju Suh, Yun Jin Choi, Moonsuk Nam, Hyoung Woo Lee, Ie Byung Park, Suk Chon, Jeong-Taek Woo, Sei Hyun Baik, Yongsoo Park, Dae Jung Kim, Kwan Woo Lee, Young Seol Kim
    Journal of Korean Medical Science.2012; 27(10): 1188.     CrossRef
  • C1q/TNF-Related Protein-3 (CTRP-3) and Pigment Epithelium-Derived Factor (PEDF) Concentrations in Patients With Type 2 Diabetes and Metabolic Syndrome
    Kyung Mook Choi, Soon Young Hwang, Ho Cheol Hong, Sae Jeong Yang, Hae Yoon Choi, Hye Jin Yoo, Kwan Woo Lee, Moon Suk Nam, Yong Soo Park, Jeong Taek Woo, Young Seol Kim, Dong Seop Choi, Byung-Soo Youn, Sei Hyun Baik
    Diabetes.2012; 61(11): 2932.     CrossRef
  • Direct Medical Costs for Patients with Type 2 Diabetes and Related Complications: A Prospective Cohort Study Based on the Korean National Diabetes Program
    Tae Ho Kim, Ki Hong Chun, Hae Jin Kim, Seung Jin Han, Dae Jung Kim, Jiyeong Kwak, Young Seol Kim, Jeong Taek Woo, Yongsoo Park, Moonsuk Nam, Sei Hyun Baik, Kyu Jeung Ahn, Kwan Woo Lee
    Journal of Korean Medical Science.2012; 27(8): 876.     CrossRef
  • Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
    Jung Hee Kim, Dae Jung Kim, Hak Chul Jang, Sung Hee Choi
    Diabetes & Metabolism Journal.2011; 35(6): 571.     CrossRef
  • Letter: The Prevalence of Peripheral Arterial Disease in Korean Patients with Type 2 Diabetes Mellitus Attending a University Hospital (Diabetes Metab J 2011;35:543-50)
    Won Jun Kim, Cheol-Young Park
    Diabetes & Metabolism Journal.2011; 35(6): 637.     CrossRef
  • Satisfaction with High Deductible Policies among Patients with Diabetes in the Korean General/University Hospital System
    Dae Jung Kim
    Journal of Korean Diabetes.2011; 12(4): 179.     CrossRef
Factors Influencing Physical Activity Behavior among Iranian Women with Type 2 Diabetes Using the Extended Theory of Reasoned Action
Alireza Didarloo, Davoud Shojaeizadeh, Hassan Eftekhar Ardebili, Shamsaddin Niknami, Ebrahim Hajizadeh, Mohammad Alizadeh
Diabetes Metab J. 2011;35(5):513-522.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.513
  • 28,925 View
  • 34 Download
  • 16 Crossref
AbstractAbstract PDFPubReader   
Background

Findings of most studies indicate that the only way to control diabetes and prevent its debilitating effects is through the continuous performance of self-care behaviors. Physical activity is a non-pharmacological method of diabetes treatment and because of its positive effects on diabetic patients, it is being increasingly considered by researchers and practitioners. This study aimed at determining factors influencing physical activity among diabetic women in Iran, using the extended theory of reasoned action in Iran.

Methods

A sample of 352 women with type 2 diabetes, referring to a Diabetes Clinic in Khoy, Iran, participated in the study. Appropriate instruments were designed to measure the desired variables (knowledge of diabetes, personal beliefs, subjective norms, perceived self-efficacy, behavioral intention and physical activity behavior). The reliability and validity of the instruments were examined and approved. Statistical analyses of the study were conducted by inferential statistical techniques (independent t-test, correlations and regressions) using the SPSS package.

Results

The findings of this investigation indicated that among the constructs of the model, self efficacy was the strongest predictor of intentions among women with type 2 diabetes and both directly and indirectly affected physical activity. In addition to self efficacy, diabetic patients' physical activity also was influenced by other variables of the model and sociodemographic factors.

Conclusion

Our findings suggest that the high ability of the theory of reasoned action extended by self-efficacy in forecasting and explaining physical activity can be a base for educational intervention. Educational interventions based on the proposed model are necessary for improving diabetics' physical activity behavior and controlling disease.

Citations

Citations to this article as recorded by  
  • Factors related to the empowerment of patients with diabetes: a cross-sectional study
    Shahla Vaziri Esferjani, Samaneh Sarizadeh, Seyed Mahmoud Latifi, Mostafa Albokordi, Marzieh Araban
    Journal of Public Health.2024; 32(2): 229.     CrossRef
  • The effectiveness of a theory-based educational intervention on promoting physical activity-related behavior in patients with chronic low back pain: a randomized controlled trial based on health center (TRA -BAC)
    Mohammad Hossein Delshad, Alireza Hidarnia, Fatemeh Pourhaji
    Scientia Medica.2024; 34(1): e455567.     CrossRef
  • Predictors of self-care behaviors and glycemic control among patients with type 2 diabetes mellitus
    Towhid Babazadeh, Yosef Lotfi, Soheila Ranjbaran
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Level of physical activity in patients with type 2 diabetes
    Mohammad Amerzadeh, Mahdie Bahrami, Fatemeh Samie, Marzieh Khatooni, Zahra Hosseinkhani, Bahareh Yousefi, Omid Taherkhani
    Journal of Diabetes & Metabolic Disorders.2023;[Epub]     CrossRef
  • Determining intention, fast food consumption and their related factors among university students by using a behavior change theory
    Alireza Didarloo, Surur Khalili, Ahmad Ali Aghapour, Fatemeh Moghaddam-Tabrizi, Seyed Mortaza Mousavi
    BMC Public Health.2022;[Epub]     CrossRef
  • Self-Care Behaviors in Patients with Hypertension to Prevent Hypertensive Emergencies: a Qualitative Study Based on the Theory of Planned Behavior
    Farnaz Eslamimehr, Zahra Hosseini, Teamur Aghamolaei, Marzieh Nikparvar, Amin Ghanbarnezhad
    Journal of Cardiovascular Emergencies.2022; 8(4): 75.     CrossRef
  • Moderate-to-vigorous physical activity changes in a diabetes prevention intervention randomized trial among South Asians with prediabetes – The D-CLIP trial
    Christopher N. Ford, Whitney L. Do, Mary Beth Weber, K.M. Venkat Narayan, Harish Ranjani, R.M Anjana
    Diabetes Research and Clinical Practice.2021; 174: 108727.     CrossRef
  • Time-varying association between physical activity and risk of diabetes in the early and late adulthood: A longitudinal study in a West-Asian country
    Parisa Naseri, Parisa Amiri, Hasti Masihay-Akbar, Navideh Sahebi Vaighan, Sajad Ahmadizad, Arash Ghanbarian, Fereidoun Azizi
    Primary Care Diabetes.2021; 15(6): 1026.     CrossRef
  • Predicting the Determinants of Nutritional Behaviors among High School Female Students: The Application of Extended Theory of Reasoned Action
    Zahra Baji, Ghodratollah Shakerinejad, Masoumeh Tehrani ‎, Farzaneh Jarvandi, Saeedeh Hajinajaf
    Journal of Education and Community Health.2020; 7(1): 37.     CrossRef
  • Predicting Covid-19 Preventive Healthy Behaviors Based on Dysfunctional Attitudes in Five Countries
    Sima Eivazi, Jahangir Karami, Peter John Varey, Sara Eivazi
    Journal of Kermanshah University of Medical Sciences.2020;[Epub]     CrossRef
  • ​The Effect of an Educational Intervention Based on Health Belief Model on Nutritional Behaviors in Type 2 Diabetics
    Dadkhah Tehrani. B, Tavakoli. R, Jazayeri. SA
    Military Caring Sciences.2019; 5(4): 303.     CrossRef
  • The effect of educational intervention based on BASNEF model on self-medication behavior of type 2 diabetic patients
    AliKhani Jeihooni, Maryam Barati, Amin Kouhpayeh, SeyyedMansour Kashfi, PooyanAfzali Harsini, Milad Rahbar
    Indian Journal of Endocrinology and Metabolism.2019; 23(6): 616.     CrossRef
  • Health-Related Quality of Life and its Determinants Amongst Women With Diabetes Mellitus: A Cross-Sectional Analysis
    Alireza Didarloo, Mohammad Alizadeh
    Nursing and Midwifery Studies.2016;[Epub]     CrossRef
  • Applying Socioecological Model to Improve Women’s Physical Activity: A Randomized Control Trial
    Hadi Tehrani, Fershteh Majlessi, Davoud Shojaeizadeh, Roya Sadeghi, Marzieh Hasani Kabootarkhani
    Iranian Red Crescent Medical Journal.2016;[Epub]     CrossRef
  • Investigating Physical Exercise among Jordanians with Diabetes Mellitus
    Muhammad W. Darawad, Sultan Mosleh, Amani A. Khalil, Mahmoud Maharmeh, Ayman M. Hamdan-Mansour, Osama A. Samarkandi
    Health.2016; 08(02): 181.     CrossRef
  • Underdiagnosis of delirium on admission and prediction of patients who will develop delirium during their inpatient stay: a pilot study
    YC Chin, GC Koh, YK Tay, CH Tan, RA Merchant
    Singapore Medical Journal.2016; 57(01): 18.     CrossRef
Serum Visfatin and Fetuin-A Levels and Glycemic Control in Patients with Obese Type 2 Diabetes Mellitus
Fethiye Oztop Gunduz, Sembol Turkmen Yildirmak, Mustafa Temizel, Yilmaz Faki, Mustafa Cakmak, Mustafa Durmuscan, Funda Sezgin
Diabetes Metab J. 2011;35(5):523-528.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.523
  • 65,535 View
  • 30 Download
  • 10 Crossref
AbstractAbstract PDFPubReader   
Background

Visfatin is an adipokine produced by visceral adipose tissue and has insulin-mimicking effects. Fetuin-A is a hepatic secretory protein that binds the insulin receptor and inhibits insulin action both in vivo and in vitro. The authors of the present study aimed to investigate the levels of serum visfatin and fetuin-A and their correlation with hemoglobin A1c (HbA1c) and urine albumin levels in patients with type 2 diabetes mellitus (T2DM).

Methods

A total of 40 obese patients with T2DM (11 males and 29 females; age, 54.47±10.83 years and 23 obese nondiabetic controls (8 males and 15 females; age, 53.04±11.33 years) were included in the study. Age, sex, and body mass index were similar in the 2 groups. Serum visfatin and fetuin-A levels were measured by enzyme-linked immunosorbent assay. HbA1c and urine albumin levels were measured by high performance liquid chromatography and nephelometric method, respectively.

Results

Serum levels of visfatin in patients with T2DM (4.03±2.44 ng/mL) were similar to the control group (3.65±3.02 ng/mL). Serum fetuin-A levels were significantly lower in patients with T2DM than the controls (298.75±78.86 and 430.73±94.46 µg/mL, respectively). HbA1c levels were significantly higher in the T2DM group compared with controls (7.33±1.32 and 5.44±0.84%, respectively). Correlations between visfatin, fetuin-A and HbA1c levels were not observed.

Conclusion

The present study suggests fetuin-A may play a role in the pathogenesis of T2DM.

Citations

Citations to this article as recorded by  
  • Assessment of serum and salivary visfatin levels in newly diagnosed patients of type-II DM
    Faith R. Jerusha, Vandana Raghunath
    Journal of Oral and Maxillofacial Pathology.2023; 27(4): 663.     CrossRef
  • Evaluation of the serum visfatin eotaxin and fetuin-A levels of patients with type 2 diabetes mellitus
    Hacer KAYHAN KAYA, Abdurrahman ŞERMET, Zafer PEKKOLAY, Ezel TAŞDEMİR, Dilek AYGÜN KEŞİM
    Anatolian Current Medical Journal.2022; 4(1): 113.     CrossRef
  • The Association Between Three Adipocytokines (Adiponectin, Resistin and Visfatin) And Thyroid Status in Patients With Type 2 Diabetes Mellitus and Autoimmune Thyroiditis
    Š. Sotak, Z. Schroner, I. Lazúrová, M. Felšőci, I. Jochmanová, D. Petrášová, I. Bertková, M. Mitníková, B. Nováková, H. Wagnerová, O. Bobelová
    Physiological Research.2021; (6): 865.     CrossRef
  • Prediction of gestational diabetes mellitus in the first trimester: comparison of maternal fetuin-A, N-terminal proatrial natriuretic peptide, high-sensitivity C-reactive protein, and fasting glucose levels
    Hatice Kansu-Celik, A. Seval Ozgu-Erdinc, Burcu Kisa, Rahime Bedir Findik, Canan Yilmaz, Yasemin Tasci
    Archives of Endocrinology and Metabolism.2019;[Epub]     CrossRef
  • The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies
    F. Roshanzamir, M. Miraghajani, M. H. Rouhani, M. Mansourian, R. Ghiasvand, S. M. Safavi
    Journal of Endocrinological Investigation.2018; 41(1): 33.     CrossRef
  • Fetuin-A level in type 2 diabetic patients: relation to microvascular complications
    Nehal H. Al-Said, Fatma M. Taha, Ghada M. Abdel-Aziz, Marwa S. Abdel-Tawab
    The Egyptian Journal of Internal Medicine.2018; 30(3): 121.     CrossRef
  • Serum levels of fetuin A are increased in women with gestational diabetes mellitus
    Ozlem Turhan Iyidir, Ceyla Konca Degertekin, Banu Aktas Yilmaz, Alev E. Altinova, Fusun B. Toruner, Nuray Bozkurt, Goksun Ayvaz, Mujde Akturk
    Archives of Gynecology and Obstetrics.2015; 291(4): 933.     CrossRef
  • Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes
    Mia Jüllig, Shelley Yip, Aimin Xu, Greg Smith, Martin Middleditch, Michael Booth, Richard Babor, Grant Beban, Rinki Murphy, Pankaj K. Singh
    PLoS ONE.2014; 9(5): e96489.     CrossRef
  • Preventive roles of swimming exercise and pioglitazone treatment on hepatic dysfunction in a rat model of metabolic syndrome
    Hussein F. Sakr, Fahaid H. Al-Hashem, Waffaa M. Hassab El-Naby, Mahmoud A. Alkhateeb, Mohamed Samir A. Zaki, Hesham M. El Refaey, Mohamed D. Morsy
    Canadian Journal of Physiology and Pharmacology.2014; 92(2): 162.     CrossRef
  • Relationship between circulating visfatin/NAMPT, nutritional status and insulin resistance in an elderly population – results from the PolSenior substudy
    Magdalena Olszanecka-Glinianowicz, Aleksander Owczarek, Maria Bożentowicz-Wikarek, Aniceta Brzozowska, Małgorzata Mossakowska, Tomasz Zdrojewski, Tomasz Grodzicki, Andrzej Więcek, Jerzy Chudek
    Metabolism.2014; 63(11): 1409.     CrossRef
Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
Hyun Jeong Jeon, Tae Keun Oh
Diabetes Metab J. 2011;35(5):529-535.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.529
  • 65,535 View
  • 108 Download
  • 25 Crossref
AbstractAbstract PDFPubReader   
Background

The present study investigated the efficacy and safety of vildagliptin-metformin treatment compared to those of glimepiride-metformin treatment for type 2 diabetes.

Methods

In a randomized, open-label, comparative study, 106 patients with type 2 diabetes were enrolled. The primary endpoint was a reduction in HbA1c from baseline and secondary endpoints included fasting plasma glucose (FPG) or 2-hour postprandial glucose (2h-PPG) reduction from baseline, as well as HbA1c responder rate and HbA1c reduction according to baseline HbA1c category.

Results

Comparable HbA1c reduction was observed with a mean±standard deviation change from baseline to the 32-week endpoint of -0.94±1.15% in the vildagliptin group and -1.00±1.32% in the glimepiride group. A similar reduction in 2h-PPG (vildagliptin group 3.53±4.11 mmol/L vs. the glimepiride group 3.72±4.17 mmol/L) was demonstrated, and the decrements in FPG (vildagliptin group 1.54±2.41 mmol/L vs. glimepiride group 2.16±2.51 mmol/L) were not different between groups. The proportion of patients who achieved an HbA1c less than 7% at week 32 was 50.1% in the vildagliptin group and 56.0% in the glimepiride group. An average body weight gain of 2.53±1.21 kg in the glimepiride group was observed in contrast with the 0.23±0.69 kg weight gain noted in the vildagliptin group. A 10-fold lower incidence of hypoglycemia was demonstrated in the vildagliptin group, in addition to an absence of severe hypoglycemia.

Conclusion

Vildagliptin-metformin treatment provided blood glucose control efficacy comparable to that of glimepiride-metformin treatment and resulted in better adverse event profiles with lower risks of hypoglycemia and weight gain.

Citations

Citations to this article as recorded by  
  • A Randomized, Two-Treatments, Two-Periods, Crossover, Open label, Laboratory-Blind, Single Dose Bioequivalence Study between Vildagliptin/Metformin 50 mg/1000 mg Film Coated Tablets (Sensityn®) and Galvusmet® 50 mg/1000 mg Film Coated Tablets in healthy a
    J. Shiekmydeen, T. Siddiqi, K. Chakraborty, S. Khalaf, M. Albarazi, I. Eqtefan, J. Sliva
    European Pharmaceutical Journal.2023; 70(2): 1.     CrossRef
  • Bioequivalence Studies of New Generic Formulations of Vildagliptin and Fixed-Drug Combination of Vildagliptin and Metformin Versus Respective Originator Products in Healthy Volunteers
    Yvonne Schnaars, Sumedh Gaikwad, Ulrike Gottwald-Hostalek, Ulrike Klingberg, Hari Kiran Chary Vadla, Vamshi Ramana Prathap
    Diabetes Therapy.2022; 13(6): 1215.     CrossRef
  • Efficacy and safety of dorzagliatin for type 2 diabetes mellitus: A meta-analysis and trial sequential analysis
    Yunfeng Yu, Xingyu Yang, Keke Tong, Shuang Yin, Gang Hu, Fei Zhang, Pengfei Jiang, Manli Zhou, Weixiong Jian
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • A Single-Center, Observational, Retrospective Cost-Effective Analysis of Treating Inadequately Controlled Type 2 Diabetes Mellitus by Addition of DPP4 Inhibitors Versus Intensified Treatment with Conventional Drugs
    Akshata Kalyani, Sachin Kuchya, >Prashant Punekar
    Journal of Pharmacology and Pharmacotherapeutics.2021; 12(3): 125.     CrossRef
  • Comparison of safety and efficacy of glimepiride-metformin and vildagliptin- metformin treatment in newly diagnosed type 2 diabetic patients
    Surendra Kumar
    Indian Journal of Endocrinology and Metabolism.2021; 25(4): 326.     CrossRef
  • Comparative clinical study evaluating the effect of adding Vildagliptin versus Glimepiride to ongoing Metformin therapy on diabetic patients with symptomatic coronary artery disease
    Rehab Werida, Mahmoud Kabel, Gamal Omran, Ahmed Shokry, Tarek Mostafa
    Diabetes Research and Clinical Practice.2020; 170: 108473.     CrossRef
  • Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta‐analysis involving eight eligible randomized‐controlled trials
    Yan Peng, Shu‐Hong Chen, Xiao‐Nan Liu, Qing‐Yun Sun
    Journal of Cellular Physiology.2019; 234(3): 2795.     CrossRef
  • A safety and tolerability profile comparison between dipeptidyl peptidase-4 inhibitors and sulfonylureas in diabetic patients: A systematic review and meta-analysis
    Daniela Farah, Graziella Malzoni Leme, Freddy Goldberg Eliaschewitz, Marcelo Cunio Machado Fonseca
    Diabetes Research and Clinical Practice.2019; 149: 47.     CrossRef
  • Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East‐Asian patients with type 2 diabetes in a multicentre, double‐blind, randomized, parallel‐arm, active comparator, phase III trial
    Yu Hong Chen, Chien‐Ning Huang, Young Min Cho, Pengfei Li, Liqun Gu, Feng Wang, Jun Yang, Wei Qing Wang
    Diabetes, Obesity and Metabolism.2018; 20(9): 2121.     CrossRef
  • Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece
    Hara Kousoulakou, Magdalini Hatzikou, Varvara Baroutsou, John Yfantopoulos
    Cost Effectiveness and Resource Allocation.2017;[Epub]     CrossRef
  • The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus
    Gyuri Kim, Sewon Oh, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee
    Expert Opinion on Pharmacotherapy.2017; 18(12): 1179.     CrossRef
  • Predictors of efficacy of GLP-1 agonists and DPP-4 inhibitors: A systematic review
    Helene Bihan, Winda L. Ng, Dianna J. Magliano, Jonathan E. Shaw
    Diabetes Research and Clinical Practice.2016; 121: 27.     CrossRef
  • New Oral Diabetes Drugs are more effective than Older Agents: Real or a Fraud?
    Udaya M Kabadi
    Journal of Diabetes, Metabolic Disorders & Control.2016;[Epub]     CrossRef
  • Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes
    Eleni Bekiari, Chrysoula Rizava, Eleni Athanasiadou, Konstantinos Papatheodorou, Aris Liakos, Thomas Karagiannis, Maria Mainou, Maria Rika, Panagiota Boura, Apostolos Tsapas
    Endocrine.2016; 52(3): 458.     CrossRef
  • Sulfonylurea Glimepiride: A Proven Cost Effective, Safe and Reliable War Horse in Combating Hyperglycemia in Type 2 Diabetes
    Udaya M. Kabadi
    Journal of Diabetes Mellitus.2015; 05(04): 211.     CrossRef
  • Glycemic effects of vildagliptin and metformin combination therapy in Indian patients with type 2 diabetes: An observational study (印度2型糖尿病患者使用维格列汀与二甲双胍联合治疗对血糖的影响:一项观察性研究)
    Sanjay Chatterjee, Sudip Chatterjee
    Journal of Diabetes.2014; 6(3): 237.     CrossRef
  • Head‐to‐head comparison of dipeptidyl peptidase‐IV inhibitors and sulfonylureas – a meta‐analysis from randomized clinical trials
    Yifei Zhang, Jie Hong, Jie Chi, Weiqiong Gu, Guang Ning, Weiqing Wang
    Diabetes/Metabolism Research and Reviews.2014; 30(3): 241.     CrossRef
  • Vildagliptin: A Review of Its Use in Type 2 Diabetes Mellitus
    Gillian M. Keating
    Drugs.2014; 74(5): 587.     CrossRef
  • Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients
    Giuseppe Derosa, Aldo Bonaventura, Lucio Bianchi, Davide Romano, Elena Fogari, Angela D’Angelo, Pamela Maffioli
    Metabolism.2014; 63(7): 957.     CrossRef
  • The Placement of DPP-4 Inhibitors in Clinical Practice Recommendations for the Treatment of Types 2 Diabetes
    Jaime A. Davidson
    Endocrine Practice.2013; 19(6): 1050.     CrossRef
  • Predictive Clinical Parameters and Glycemic Efficacy of Vildagliptin Treatment in Korean Subjects with Type 2 Diabetes
    Jin-Sun Chang, Juyoung Shin, Hun-Sung Kim, Kyung-Hee Kim, Jeong-Ah Shin, Kun-Ho Yoon, Bong-Yun Cha, Ho-Young Son, Jae-Hyoung Cho
    Diabetes & Metabolism Journal.2013; 37(1): 72.     CrossRef
  • The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes
    Jun Sung Moon, Kyu Chang Won
    Diabetes & Metabolism Journal.2013; 37(1): 36.     CrossRef
  • Effect of Vildagliptin on Glucose and Insulin Concentrations During a 24-Hour Period in Type 2 Diabetes Patients with Different Ranges of Baseline Hemoglobin A1c Levels
    Manuel González-Ortiz, María J. Sánchez-Peña, Luis J. González-Ortiz, José A. Robles-Cervantes, Yessica E. García-Ortega, Esteban A. Gómez-Gaitán, Karina G. Pérez-Rubio, Esperanza Martínez-Abundis
    Diabetes Technology & Therapeutics.2013; 15(7): 564.     CrossRef
  • Differential effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus assessed using continuous glucose monitoring
    Y. L. He, G. Foteinos, S. Neelakantham, D. Mattapalli, K. Kulmatycki, T. Forst, A. Taylor
    Diabetes, Obesity and Metabolism.2013; 15(12): 1111.     CrossRef
  • Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus
    Elisa Guarino, Laura Nigi, Aurora Patti, Cecilia Fondelli, Francesco Dotta
    Expert Opinion on Pharmacotherapy.2012; 13(9): 1377.     CrossRef
Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients
Sunghwan Suh, Hyung-Doo Park, Se Won Kim, Ji Cheol Bae, Alice Hyun-Kyung Tan, Hye Soo Chung, Kyu Yeon Hur, Jae Hyeon Kim, Kwang-Won Kim, Moon-Kyu Lee
Diabetes Metab J. 2011;35(5):536-542.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.536
  • 4,996 View
  • 39 Download
  • 14 Crossref
AbstractAbstract PDFPubReader   
Background

Small dense low density lipoprotein (sdLDL) has recently emerged as an important risk factor of coronary heart disease.

Methods

The mean LDL particle size was measured in 203 patients with type 2 diabetes mellitus (T2DM) and 212 matched subjects without diabetes using polyacrylamide tube gel electrophoresis. Major vascular complications were defined as stroke, angiographically-documented coronary artery disease or a myocardial infarction. Peripheral vascular stenosis, carotid artery stenosis (≥50% in diameter) or carotid artery plaque were considered minor vascular complications. Overall vascular complications included both major and minor vascular complications.

Results

Diabetic patients had significantly smaller mean-LDL particle size (26.32 nm vs. 26.49 nm) and a higher percentage of sdLDL to total LDL compared to those of subjects without diabetes (21.39% vs. 6.34%). The independent predictors of sdLDL in this study were serum triglyceride level and body mass index (odds ratio [OR], 1.020 with P<0.001 and OR 1.152 with P<0.027, respectively). However, no significant correlations were found between sdLDL and major vascular complications (P=0.342), minor vascular complications (P=0.573) or overall vascular complications (P=0.262) in diabetic subjects.

Conclusion

Diabetic patients had a smaller mean-LDL particle size and higher proportion of sdLDL compared to those of subjects without diabetes. Obese diabetic patients with hypertriglyceridemia have an increased risk for atherogenic small dense LDL. However, we could not verify an association between LDL particle size and vascular complications in this study.

Citations

Citations to this article as recorded by  
  • Evaluation of measured and calculated small dense low-density lipoprotein in capillary blood and association with the metabolic syndrome
    Sara Deza, Inmaculada Colina, Oscar Beloqui, José Ignacio Monreal, Estéfani Martínez-Chávez, Julia Maroto-García, Carmen Mugueta, Alvaro González, Nerea Varo
    Clinica Chimica Acta.2024; 557: 117897.     CrossRef
  • Association between measured or calculated small dense low‐density lipoprotein cholesterol and oxidized low‐density lipoprotein in subjects with or without type 2 diabetes mellitus
    Hyun‐Ki Kim, Jinyoung Hong, Sunyoung Ahn, Woochang Lee, Sail Chun, Won‐Ki Min
    Journal of Clinical Laboratory Analysis.2023;[Epub]     CrossRef
  • The association of apolipoprotein in the risk of ST-elevation myocardial infarction in patients with documented coronary artery disease
    Astuti Giantini, Nur Gifarani Pratiwi, Renan Sukmawan, Joedo Prihartono, Suzanna Immanuel, Merci Monica Pasaribu, Sri Suryo Adiyanti, Yusuf Bahasoan
    International Journal of Cardiology Cardiovascular Risk and Prevention.2023; 18: 200194.     CrossRef
  • Atherogenic Index of Plasma and Its Association with Risk Factors of Coronary Artery Disease and Nutrient Intake in Korean Adult Men: The 2013–2014 KNHANES
    Hye Ran Shin, SuJin Song, Jin Ah Cho, Sun Yung Ly
    Nutrients.2022; 14(5): 1071.     CrossRef
  • The Atherogenic Index of Plasma: A Powerful and Reliable Predictor for Coronary Artery Disease in Patients With Type 2 Diabetes
    Kuo Zhou, Zheng Qin, Jinfan Tian, Kongyong Cui, Yunfeng Yan, Shuzheng Lyu
    Angiology.2021; 72(10): 934.     CrossRef
  • Direct bilirubin is associated with low-density lipoprotein subfractions and particle size in overweight and centrally obese women
    Y.-J. Kwon, H.-S. Lee, J.-W. Lee
    Nutrition, Metabolism and Cardiovascular Diseases.2018; 28(10): 1021.     CrossRef
  • Correlation between Cholesterol, Triglycerides, Calculated, and Measured Lipoproteins: Whether Calculated Small Density Lipoprotein Fraction Predicts Cardiovascular Risks
    Sikandar Hayat Khan, Nadeem Fazal, Athar Abbas Gilani Shah, Syed Mohsin Manzoor, Naveed Asif, Aamir Ijaz, Najmusaqib Khan Niazi, Muhammad Yasir
    Journal of Lipids.2017; 2017: 1.     CrossRef
  • Effects of Small Dense LDL in Diabetic Nephropathy in Females with Type 2 Diabetes Mellitus
    Seongyul Ryu, Youngwoo Kim, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Hyun Baek, Ki-Ho Song, Kyung-Jin Yun
    Journal of Lipid and Atherosclerosis.2016; 5(1): 11.     CrossRef
  • Prepregnancy Adverse Lipid Profile and Subsequent Risk of Gestational Diabetes
    Emily S. Han, Ronald M. Krauss, Fei Xu, Sneha B. Sridhar, Assiamira Ferrara, Charles P. Quesenberry, Monique M. Hedderson
    The Journal of Clinical Endocrinology & Metabolism.2016; 101(7): 2721.     CrossRef
  • Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus
    Xiao-Wei Zhu, Fei-Yan Deng, Shu-Feng Lei
    Primary Care Diabetes.2015; 9(1): 60.     CrossRef
  • Higher levels of small dense low‐density lipoprotein (LDL) are associated with cardiac autonomic neuropathy in patients with Type 2 diabetes
    E.‐H. Jang, Y.‐M. Park, J. Hur, M.‐K. Kim, S.‐H. Ko, K.‐H. Baek, K.‐H. Song, K.‐W. Lee, H.‐S. Kwon
    Diabetic Medicine.2013; 30(6): 694.     CrossRef
  • Sleep Status and Low-Density Lipoprotein Particle Size in a General Japanese Female Population: The Mima Study
    Kazuhiko Kotani, Kokoro Tsuzaki, Shinji Fujiwara, Naoki Sakane
    Medical Principles and Practice.2013; 22(5): 510.     CrossRef
  • Serum small-dense LDL abnormalities in chronic renal disease patients
    M. Chu, A. Y. M. Wang, I. H. S. Chan, S. H. Chui, C. W. K. Lam
    British Journal of Biomedical Science.2012; 69(3): 99.     CrossRef
  • Small Dense Low-density Lipoprotein and Cardiovascular Disease
    Sunghwan Suh, Moon-Kyu Lee
    Journal of Lipid and Atherosclerosis.2012; 1(1): 1.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer